QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-K

FOR ANNUAL AND TRANSITION REPORTS
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

(Mark One)  

ý

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 28, 2002

or

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from                        to            

Commission File No. 1-12620


PLAYTEX PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)
  51-0312772
(I.R.S. Employer Identification No.)

300 Nyala Farms Road
Westport, Connecticut 06880

(Address of principal executive offices)

Telephone number:
(203) 341-4000
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

 

 
 
Title of each class

  Name of each exchange
on which registered

Common Stock, par value $.01 per share   New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:
None

        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes ý        No o

        Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendments of this Form 10-K ý.

        Indicate by check whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act).

Yes ý        No o

        The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 28, 2002 was $382,133,599 (based on the closing sale price of $12.95 on June 28, 2002 as reported by the New York Stock Exchange-Composite Transactions). For this computation, the registrant has excluded the market value of all shares of its Common Stock reported as beneficially owned by named executive officers and directors of the registrant; such exclusion shall not be deemed to constitute an admission that any such person is an "affiliate" of the registrant.

        At March 25, 2003, 61,215,856 shares of Playtex Products, Inc. common stock, par value $.01 per share, were outstanding.




Documents incorporated by reference:

Document

  Part of Form 10-K
Portions of our definitive Proxy Statement (the "Proxy Statement") for our 2003 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days after the end of our fiscal year ended December 28, 2002 pursuant to Regulation 14A   III

2



TABLE OF CONTENTS

 
   
  Page
    PART I    
Item 1.   Business   5
    Risk Factors   18
Item 2.   Properties   21
Item 3.   Legal Proceedings   21
Item 4.   Submission of Matters to a Vote of Security Holders   22

 

 

PART II

 

 

Item 5.

 

Market for Registrant's Common Equity and Related Stockholder Matters

 

23
Item 6.   Selected Financial Data   23
Item 7.   Management's Discussion and Analysis of Financial Condition and Results of Operations   23
Item 7A.   Quantitative and Qualitative Disclosure about Market Risk   23
Item 8.   Financial Statements and Supplementary Data   24
Item 9.   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   24

 

 

PART III

 

 

Item 10.

 

Directors and Executive Officers of the Registrant

 

24
Item 11.   Executive Compensation   24
Item 12.   Security Ownership of Certain Beneficial Owners and Management   24
Item 13.   Certain Relationships and Related Transactions   24
Item 14.   Controls and Procedures   24

 

 

PART IV

 

 

Item 15.

 

Exhibits, Financial Statement Schedule and Reports on Form 8-K

 

25
    Signatures   27

3



PART I

Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the Private Securities Litigation Reform Act of 1995

        This document includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future results. When we use words in this document such as "anticipates," "intends," "plans," "believes," "estimates," "expects," and similar expressions we do so to identify forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements. These forward-looking statements are affected by risks, uncertainties, and assumptions that we make, including, among other things, the Risk Factors that are listed in Part 1, Item I. of this Annual Report on Form 10-K and:

  price and product changes,     impact of weather conditions, especially
  promotional activity by competitors,           on Sun Care product sales,
  the loss or bankruptcy of a significant customer,     our level of debt and its restrictive covenants,
  capacity limitations,     interest rate fluctuations,
  the difficulties of integrating acquisitions,     future cash flows,
  raw material and manufacturing costs,     dependence on key employees, and
  adverse publicity and product liability claims,     highly competitive nature of consumer products
    business.

You should keep in mind that any forward-looking statement made by us in this document, or elsewhere, speaks only as of the date on which we make it. New risks and uncertainties come up from time to time, and it's impossible for us to predict these events or how they may affect us. In light of these risks and uncertainties, you should keep in mind that any forward-looking statements made in this report or elsewhere might not occur.

        On November 13, 2002, we announced our intent to undertake a process to evaluate strategic alternatives for maximizing shareholder value. The strategic alternatives to be considered include, but are not limited to, business combinations with one or more parties to form a larger personal care and household products company, selling the entire company, divesting one or more lines of business, and acquiring strategic lines of business. We cannot assure you that this process will result in a transaction.

        In addition, the preparation of financial statements in accordance with accounting principles generally accepted in the United States requires us to make estimates and assumptions. These estimates and assumptions affect:

Actual results may vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make as well as assumptions by third parties. The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware (see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies of this Annual Report on Form 10-K). As part of our customary review and reconciliation process, we periodically record adjustments to our accounting estimates. During the second quarter ended June 29, 2002, we recorded additional expenses of $2.0 million to cover higher than expected Sun Care returns from the 2001 Sun Care season. Also, we reduced our reserves for certain advertising and sales promotion programs conducted prior to 2002 by $1.7 million based on the actual costs of these programs versus our original estimates.

4


Trademarks

        We have proprietary rights to a number of trademarks important to our business, such as: Active Sport, Baby Magic (in United States and Canada), Banana Boat, Binaca, Binky, Blasters, Big Sipster, CoolStraw, Diaper Genie, Dentax, DrinkUp, Drop-Ins, Fast Blast, Gentle Glide, Get On The Boat, Gripster, HandSaver, Heat Therapy, Heavy Traffic, Insulator, LipPops, Most Like Mother, Mr. Bubble, Natural Action, Ogilvie, Oxy Deep, Power Blasts, Power Shot, Precisely Right, QuickStraw, Quik Blok, Safe'N Sure, Silk Glide, SipEase, Slimfits, Soft Comfort, Sooth-A-Caine, Suntanicals, Tub Mate, Tek, Tussy, VentAire, VitaSkin, and Wet Ones. We also own a royalty free license in perpetuity to the Playtex and Living trademarks, and to the Woolite trademark for rug and upholstery cleaning products in the United States and Canada.

        All references to market share and market share data are for comparable 52 week periods and represent our percentage of the total U.S. dollar volume of products purchased by consumers in the applicable category (dollar market share, or retail consumption). This information is provided to us from the ACNielsen Company ("ACNielsen") and is subject to revisions. During 2001, Wal-Mart Stores, Inc. ("Walmart"), ceased providing scanner/consumption data to third parties. As a result, ACNielsen restated consumption data for fiscals 2001 and 2000 to exclude Walmart consumption data.


Item 1. Business

A. History

        The Company was founded in 1932 as The International Latex Company (later International Playtex) as a manufacturer using latex-based technology. We introduced our first latex gloves in 1954 and acquired a tampon manufacturer in the mid-1960's, in addition to introducing our first disposable baby bottles and nipples. As such, we were an early manufacturer and marketer of infant feeding products, tampon and latex glove products and we developed strong leadership positions in each category. In 1988, our women's apparel operations were spun off and are currently owned by Sara Lee Corporation. During the mid/late 1990's, we made a series of strategic acquisitions, which have diversified and strengthened our product portfolio, including Banana Boat and Woolite in 1995; Wet Ones, Ogilvie, Binaca, Mr. Bubble and others in 1998; as well as Diaper Genie and Baby Magic in 1999. Throughout our history, Playtex has grown through industry leading product innovation and portfolio enhancing acquisitions of leading North American brands.

B. Executive Officers of Registrant

        Listed below are our executive officers and a short description of their prior work experiences. There are no family relationships or arrangements between any of them pursuant to which they were hired or promoted by the Company. Ages and positions are shown as of March 15, 2003.

Name

  Age
  Position
Michael R. Gallagher   57   Chief Executive Officer and Director
Glenn A. Forbes   52   Executive Vice President, Chief Financial Officer and Director
Kevin M. Dunn   50   President, Consumer Products Division
John D. Leahy   49   President, International/Corporate Sales Division
Richard G. Powers   57   President, Personal Products Division
James S. Cook   51   Senior Vice President, Operations
Paul A. Siracusa, Ph.D.   46   Senior Vice President, Research and Development
Paul E. Yestrumskas   51   Vice President, General Counsel and Secretary
Frank M. Sanchez   52   Vice President, Human Resources
Vincent S. Viviani   50   Vice President, Quality Systems

5


        Michael R. Gallagher has been Chief Executive Officer and a Director since 1995. Prior to joining the Company, Mr. Gallagher was Chief Executive Officer of North America for Reckitt & Colman PLC ("R&C") (a consumer products company) from 1994 to 1995. Mr. Gallagher was President and Chief Executive Officer of Eastman Kodak's L&F Products subsidiary from 1988 until the subsidiary was sold to R&C in 1994. From 1984 to 1988, Mr. Gallagher held various executive positions with the Lehn & Fink Group of Sterling Drug. From 1982 to 1984, he was Corporate Vice President and General Manager of the Household Products Division of the Clorox Company ("Clorox"). Prior to that, Mr. Gallagher had various marketing and general management assignments with Clorox and with the Procter & Gamble Company ("P&G"). Presently he serves as a director of Allergan, Inc., AMN Healthcare Services, Inc., the Association of Sales and Marketing Companies, the Grocery Manufacturers Association, and the Haas School of Business—UC Berkley.

        Glenn A. Forbes has been Executive Vice President, Chief Financial Officer and a Director since 2000. He has served the Company for the past 31 years in various finance and accounting positions, including Vice President, Finance from 1988 to 2000.

        Kevin M. Dunn has been President, Consumer Products Division since 2000. Prior to joining us, Mr. Dunn was President of R&C's North American Household Products Division from 1998 to 2000 and President, Food Products Division—North America from 1994 to 1997. He also held various executive positions with Eastman Kodak's L&F Products subsidiary from 1988 until the subsidiary was sold to R&C in 1994.

        John D. Leahy has been President of the International/Corporate Sales Division since 2000 and Senior Vice President, International/Corporate Sales from 1998 to 2000. He was Vice President of International/Corporate Sales from 1996 to 1998 and our Vice President of Sales from 1993 to 1996. From 1982 to 1993, Mr. Leahy held various sales positions with the Company.

        Richard G. Powers has been President, Personal Products Division since 1996. Prior to joining us, Mr. Powers was President of R&C's North American Personal Products Division. From 1992 to 1995, he was Vice President of Sales for R&C, and from 1990 to 1992 he was Vice President of Marketing for R&C's Durkee-French Foods Division. From 1973 to 1990, Mr. Powers held various positions in marketing and general management at General Foods Corp.

        James S. Cook has been Senior Vice President, Operations since 1991. From 1990 to 1991, he was our Vice President of Dover Operations. From 1988 to 1990, he was our Vice President of Distribution, Logistics & Management Information Systems. From 1982 to 1988, Mr. Cook held various senior level positions in manufacturing and distribution with us. From 1974 to 1982, he held various manufacturing and engineering positions at P&G.

        Paul A. Siracusa, Ph.D. has been Senior Vice President, Research and Development since 2000. From 1997 to 2000, he was Senior Vice President Research and Development for R&C. From 1995 to 1997, he was Divisional Vice President of Research & Development, North America for R&C. From 1992 to 1995, he was Director of Technology for the Lehn & Fink Group of Sterling Drug. Prior to that, he held various Research and Development positions with Henkel Corporation, International Flavors and Fragrances, and Union Carbide Corporation.

        Paul E. Yestrumskas has been Vice President, General Counsel and Secretary since 1995. Prior to joining us, Mr. Yestrumskas was Senior Counsel of Rhone-Poulenc, Inc. from 1991 to 1995. Prior to 1991, Mr. Yestrumskas held various positions in legal and government relations at Timex, Hubbell, Inc. and General Motors.

        Frank M. Sanchez has been Vice President of Human Resources for the Company since 1990. From 1987 to 1990, Mr. Sanchez was Vice President of Human Resources for Signal Apparel. Prior to that, he held various positions with Owens-Illinois and the American Can Company.

        Vincent S. Viviani has been Vice President of Quality Systems since 1998. Mr. Viviani was Director of Canadian & External Manufacturing for Reckitt & Colman from 1994 to 1998 and held the same position for Eastman Kodak's L&F Products subsidiary from 1988 to 1994. Prior to that, he held various manufacturing and distribution positions at Revlon.

6


C. General

        We are a leading manufacturer and marketer of a diversified portfolio of well-recognized branded consumer and personal products, including:

  Playtex Infant Care products,     Banana Boat Sun Care products,
  Playtex Diaper Genie,     Woolite rug and upholstery cleaning products,
  Wet Ones pre-moistened towelettes,     Playtex Gloves,
  Baby Magic baby toiletries,     Ogilvie home permanent products, and
  Playtex Feminine Care products,     Binaca breath freshener products.

        In fiscal 2002, approximately 97% of our net sales came from products in which we held the number one or two market share position in the United States. Products in which we held the number one U.S. market share position for fiscal 2002 and their dollar market share in their respective categories were:

  Diaper Genie diaper pails (93%),     Playtex cups and mealtime products (48%),
  Playtex disposable liners (85%),     Binaca liquid breath freshener products (39%),
  Ogilvie home permanent products (72%),     Playtex Gloves (30%), and
  Wet Ones pre-moistened towelettes (63%),     Mr. Bubble children's bubble bath (27%).

Products in which we held the number two U.S. market share position for fiscal 2002 and their dollar market share in their respective categories were:

  Playtex tampons (30%),     Banana Boat Sun Care products (22%), and
  Woolite rug and upholstery cleaning products (24%),     Baby Magic baby toiletries (9%).

        In May 2000, the Emerging Issues Task Force ("EITF") of the Financial Accounting Standards Board ("FASB") reached a consensus on Issue No. 00-14, "Accounting for Certain Sales Incentives." In April 2001, the EITF of the FASB reached a consensus on Issue No. 00-25, "Vendor Income Statement Characterization of Consideration from a Vendor to a Reseller." In November of 2001, both of these EITFs were codified in with related issues into EITF No. 01-9, "Accounting for Consideration Given By a Vendor To a Customer (Including a Reseller of the Vendor's Products)." We adopted the requirements of these Issues effective December 30, 2001, the start of our fiscal year 2002. These issues address the recognition, measurement, and income statement classification for certain advertising, promotional and cooperative spending activities. As a result of the adoption of these issues, we reclassified certain previously reported selling, general and administrative expenses to offset net sales to conform to our current year presentation. These reclassifications reduced both our net sales and selling, general and administrative expenses by equal and offsetting amounts and had no impact on our reported operating earnings, net income, or earnings per share (see Note 2 of Notes to Consolidated Financial Statements).

7


 
   
  Twelve Months Ended
Product Line

  2002 Principal Brand Names
  Dec. 28,
2002

  Dec. 29,
2001

  Dec. 30,
2000

 
   
  (Dollars in millions)

Personal Products Division:                      
  Infant Care   Playtex, Wet Ones, Mr. Bubble, Diaper Genie, and Baby Magic   $ 226.1   $ 231.2   $ 243.9
  Feminine Care   Playtex   196.1
  190.6
  189.4
    Total Personal Products Division         422.2     421.8     433.3
Consumer Products Division:                      
  Sun Care   Banana Boat     83.3     93.0     95.5
  Household Products/Personal Grooming   Playtex, Woolite, Ogilvie, Binaca, Tussy, Tek, and Dentax   76.5
  78.9
  78.9
    Total Consumer Products Division         159.8     171.9     174.4
International/Corporate Sales Division       137.1
  129.8
  125.7
    Total       $ 719.1   $ 723.5   $ 733.4
       
 
 

D. Business Segments and Product Lines

        We are organized in three divisions, which allows us to focus more effectively on individual product lines, category management initiatives and certain specialty classes of trade. Our two largest divisions, the Personal Products Division and the Consumer Products Division, constituted approximately 81% of our consolidated net sales in fiscal 2002 compared to 82% in fiscal 2001 and 83% in fiscal 2000.

        Personal Products Division—The Personal Products Division accounted for approximately 59% of our consolidated net sales in fiscal 2002 compared to 58% in fiscal 2001 and 59% in fiscal 2000. This Division includes Infant Care and Feminine Care products sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Infant Care product category includes:

Infant Feeding Products   Other Infant Care Products
  Playtex disposable nurser systems,     Diaper Genie diaper disposal system,
  Playtex cups and mealtime products,     Wet Ones pre-moistened towelettes,
  Playtex reusable hard bottles,     Baby Magic baby toiletries,
  Playtex pacifiers,     Baby Magic baby wipes, and
          Mr. Bubble children's bubble bath.

        The Feminine Care product category includes a wide range of plastic and cardboard applicator tampons, as well as complementary products, marketed under such brand names as:

Tampons   Complementary Products
  Playtex Gentle Glide,     Playtex Personal Cleansing Cloths
  Playtex Portables,           for use in feminine hygiene, and
  Playtex Slimfits,     Playtex Heat Therapy patch to
  Playtex Silk Glide,           alleviate discomfort associated
    with menstrual pain.

        Infant Care—Infant Care accounted for approximately 54% of Personal Products net sales in fiscal 2002 compared to 55% in fiscal 2001 and 56% in fiscal 2000.

        Our largest Infant Care business is infant feeding products, in which we held a market leading 35% dollar market share in 2002. We are particularly strong in both the disposable feeding and the infant cup categories with 2002 dollar market shares of 85% and 48%, respectively. We are also strong in the diaper pail category with our 93% dollar market share leading Diaper Genie brand. In pre-moistened towelettes, our Wet Ones brand held a 63% dollar market share of

8


the hand and face segment. Our Mr. Bubble brand held a 27% dollar market share of the bath additives category and became the market share leader in this category during fiscal 2002. Baby Magic held a 9% dollar market share of the infant toiletries category and is strong in the lotions and bath segments with 17% and 16% dollar market shares of those segments.

        Our strategy for maintaining market leadership positions is centered on:

        Disposable Feeding & Reusable Bottles—We offer both disposable feeding systems and reusable bottles in addition to nipples and other complementary products marketed under the Playtex brand. Historically, we have focused on the disposable segment, as we believe that disposable bottle liners are healthier and more convenient than traditional reusable bottles. The disposable collapsible liner placed inside the holder limits the amount of air in-take by the baby and reduces painful spit-ups and burping.

        In 1996, we launched Drop-Ins, a significant enhancement to the disposable product line. Drop-Ins, patented, ready-formed disposable liners, made disposable liners much easier for parents to use and since its introduction has been the driving force behind our market share gains. Our disposable feeding systems currently account for 85% of the product category.

        In an effort to broaden our product offerings in the reusable bottle segment, we developed VentAire in 1998. The VentAire bottle, has a patented air venting system that allows air to escape as the baby sucks on the nipple, much like the benefits of a disposable bottle.

        Cups—In 1994, we introduced the spill-proof cup, an innovation that changed the infant cup category. Prior to this introduction, there was no real distinct market segment for children's cups. With the launch of the spill-proof line, the category has expanded from $34 million of retail sales to more than $100 million in 2002. Over the past few years, we have introduced new products to expand our offerings in the cups segment, including the QuickStraw cup, the CoolStraw cup, the Big Sipster, a cup targeted at older children, and the Gripster, made to fit small hands. In 2002, we introduced the Insulator cup line, representing the next generation in cup technology. The Insulator cup is designed to maintain the temperature and freshness of liquids for a longer period of time. We held a market leading 48% dollar market share in 2002. In 2003, we will introduce the Insulator Sport, a new insulated leak-proof cup with a flip top straw lid for growing kids and a new trainer cup for toddlers, The First Sipster.

        Diaper Disposal Systems—Diaper Genie, which we acquired in 1999, leads the diaper disposal market with a 93% dollar market share in 2002. The Diaper Genie business is comprised of two segments:

        The diaper pail unit individually seals diapers in an odor-proof, germ-proof chain. The unit uses our proprietary refill liners, which typically lasts approximately one month. In 2001, we improved the diaper pail unit and introduced a new liner. We improved the cutter cap system, which makes the unit easier to use and we introduced a toddler film refill to the market for older age children, targeted to extend the usage period. A large percentage of the diaper pail units are given to expectant mothers as gifts. This provides a unique opportunity to begin cross-marketing our entire line of infant care products before the baby arrives.

        Baby Toiletries—Baby Magic, which we acquired in 1999, occupies the number two position among the branded products in the U.S. baby toiletries category (defined as lotions, shampoos, powders, bath products, oils and gift packs), with a 9% dollar market share in 2002. Baby Magic is strongest in the lotions and bath segments with 17% and 16% dollar market shares, respectively. The U.S. baby toiletries category has been extremely competitive since our acquisition of the Baby Magic brand in 1999. In the second quarter of 2002, we introduced a new line of Baby Magic Calming Milk products including a foaming bath, bath lotion and massage lotion. Our dollar market share in the lotions and bath segments has increased since our launch of these products. Our market share results, in the fourth quarter of 2002, were our best since the second quarter of 2001. Our retail consumption increased 9.8% in the fourth quarter of 2002, while the category

9



decreased 0.4% compared to the fourth quarter of 2001. Our full year 2002 dollar market share is down slightly compared to 2001.

        Pre-moistened towelettes—Early in 1998 we acquired Wet Ones, the market share leader in the hands and face segment of the market with a 63% dollar market share in 2002. Wet Ones are used by parents and others in applications other than diaper changing, such as cleaning up after meals or traveling away from home. The pre-moistened towelette category experienced rapid growth over the last few years as competitors entered the category and invested heavily in advertising and promotion to generate trial of their product. After two years of significant category growth, retail consumption in the category slowed in 2002, increasing 0.4% compared to 2001. Our retail consumption increased 2.3% and our dollar market share increased 1.2 percentage points compared to 2001.

        Other Infant Care Brands—We also entered the children's bubble bath and baby wipe categories in early 1998 with the acquisition of the Mr. Bubble, Chubs and Diaparene brands. Our Mr. Bubble children's bubble bath brand is a widely recognized brand name among consumers and became the market share leader in the bath additives category, in 2002, with a 27% dollar market share. In fiscal 2000, we decided to market our domestic baby wipes under the Baby Magic name and we continue to market Chubs internationally.

        Our infant care marketing is focused on a specific group of people: new and expectant mothers. These consumers undertake an immense amount of research and education, both before the child is born and after, to enhance their ability to make informed decisions concerning the health and welfare of their new infants. As such, we utilize techniques to communicate with parents in addition to traditional media advertising. Programs directed at new mothers include the distribution of millions of samples and coupons prenatally via childbirth instructors and postnatally in hospitals. The Company also provides educational materials to pediatricians, lactation consultants and hospitals such that new parents receive professional recommendations to use our infant care products. In addition, we have developed the website www.playtexbaby.com to provide information to new and expectant mothers as well as to introduce and market our entire line of infant care products. Across our entire infant care products, we communicate an image of quality, health, innovation and convenience to attract and retain users.

        Feminine CarePlaytex Feminine Care accounted for approximately 46% of Personal Products net sales in fiscal 2002 compared to 45% in fiscal 2001 and 44% in fiscal 2000. In the tampon category, consumer purchases are driven primarily by comfort, quality, protection and value, leading to intensely strong brand loyalties. For over 20 years, Playtex has been the second largest selling tampon brand overall in the U.S. and currently holds the largest position in the higher growth plastic applicator and deodorant segments. We have been able to consistently grow our share of the tampon category through a strategy of:

10


        For fiscal 2002, we had a 30% share of the tampon category. Since 1996, we have grown our overall share of the tampon category by more than 5 points and the share differential between Playtex and the category share leader has narrowed from approximately 23 points in 1996 to less than 10 points in 2002.

        Late in the third quarter of 2002, the market share leader in the tampon category introduced a new plastic tampon product supported with extensive advertising and promotional spending. Our dollar market share in the tampon category decreased 2.7 percentage points in the fourth quarter of 2002 due, in part, to the heavily promoted new competitive product. For the first two months of 2003, the market share trend is stable with that of the fourth quarter of 2002, however it continues to lag behind similar year ago periods. We intend to aggressively defend our market share in the tampon category with advertising support and the introduction of two product improvements including an improved soft pearlized plastic applicator and an improved deodorant fragrance, each of which is intended to enhance consumer benefits. The improved product will be introduced by the first quarter of 2003 and should broadly reach retail shelves in the second quarter.

        Plastic applicator tampons—Historically, our core strength has resided in plastic applicator tampons where Playtex is the clear leader with a 61% 2002 dollar market share of the plastic applicator segment. Plastic applicator tampons represent approximately 87% of our feminine care business. We believe the plastic applicator segment enjoys superior growth dynamics as these products offer greater comfort and ease of insertion/removal to the user, are popular among younger demographics and are premium priced relative to cardboard and digital applicator products.

        Gentle Glide is our most significant plastic applicator tampon. These soft plastic applicator tampons were designed with a smooth rounded tip and a unique double-layer construction, allowing for ease of insertion and comfortable fit as well as reliable leakage protection. Our Gentle Glide line has provided a platform to launch new product enhancements. For example, in 1997, we introduced the Odor Absorbing product line that was the first to contain all natural material that absorbs odors without the use of a fragrance or deodorant. This line was developed to appeal to the large group of women who are concerned with odor protection, yet reluctant to use a fragranced tampon.

        Portables were developed to provide maximum convenience and portability. To meet consumer demand for smaller products, Portables have a compact construction with a two-piece applicator that allows the user to discreetly transport and easily assemble the product to a full-sized applicator. Additionally, Portables are associated with the same level of quality and protection as Gentle Glide products.

        Slimfits, introduced in 1996, are designed to appeal to a key niche segment of the tampon category: young teenagers. The introduction of Slimfits was a direct result of our strategy to focus on first-time, feminine care product users. To promote Slimfits, we utilized focused teen awareness campaigns and targeted product sampling. Slimfits have a narrower applicator and pledget providing for greater comfort and ease of insertion. We believe Slimfits will continue to build our business over the long-term by encouraging young women to use tampons rather than pads at an earlier age and by developing brand loyalty for our tampons at a time when lifelong preferences are forming. We believe these teenagers will develop a loyalty to the Playtex brand and they will naturally transition to the Gentle Glide line.

        Cardboard applicator tampons—Cardboard applicator tampons represented approximately 8% of Personal Products feminine care business net sales in fiscal 2002. We have a full line of cardboard applicator tampons to provide a complete portfolio of product offerings to consumers and to best match a broader array of consumer preferences. Users tend to be loyal to one form of applicator over another; thus, the introduction of a cardboard applicator to the tampon product portfolio has allowed us to leverage the Playtex brand name to capture a share of the cardboard applicator segment.

        Silk Glide is our line of cardboard applicator tampons. This line features a rounded-tip cardboard applicator and a unique surface coating which aims to provide the user with a high quality product in the cardboard applicator segment of the tampon category. This product is designed to provide similar comfort and ease of insertion found in plastic applicator tampons. Moreover, the Silk Glide line also serves as a platform to launch product extensions such as our Silk Glide Odor Absorbing Tampons, the only product of its type in the cardboard segment.

11


        Complementary feminine care products—We recently introduced two new complementary feminine care products leveraging the consumer trust and strong brand awareness of our tampon franchise. We have been successful in working with retailers to merchandise these products in the feminine care aisle alongside our tampons to best leverage the Playtex brand name. These products demonstrate our ability to expand the category beyond tampons and should provide incremental sales growth going forward.

        In 2001, we introduced Personal Cleansing Cloths, pre-moistened towelettes for feminine hygiene. It has become the #1 brand in this small but growing niche category. Our Personal Cleansing Cloths are formulated with vitamin E and aloe and offer antibacterial efficacy.

        We introduced the Playtex Heat Therapy patch in July 2002. We believe there is potential for this product based upon research results and positive retailer feedback. Designed to be discrete and alleviate the discomfort associated with menstrual cramps for up to 12 hours, the Playtex patch is differentiated from other heat patches marketed to alleviate other types of discomfort.

        Consistent with our overall marketing strategy, our marketing efforts in Feminine Care have leveraged the strength of the Playtex brand that caters to the active, young female. Employing a "pull" strategy, we focus on advertising and selective consumer promotional activity to build our brand equity. Our Feminine Care marketing strategy centers on attracting first-time users and converting feminine protection pad users to tampon users by communicating the advantages of tampon usage. To that end, several recent advertising campaigns have highlighted the "diaper-like", "bulky" nature of the feminine protection pad while promoting the comfort and convenience of tampons. Given our singular focus on tampons, we believe that we are well positioned among our competitors to endorse tampons over pads and we hope to capture a disproportionately high number of new users.

        Consumer Products Division—The Consumer Products Division accounted for approximately 22% of our consolidated net sales in fiscal 2002 compared to 24% in fiscal 2001 and 2000. This division includes Sun Care, Household Products, and Personal Grooming products sold in the United States, primarily to mass merchandisers, grocery and drug classes of trade.

        Sun Care—Our Sun Care business consists of an extensive line of sun care products marketed under the Banana Boat trade name and accounted for approximately 52% of Consumer Products net sales in fiscal 2002, 54% in fiscal 2001, and 55% in fiscal 2000. Our offerings consist of an extensive line of sun care products designed for specific uses, such as sun protection with sun protection factors ("SPFs") from 4 to 50, waterproof and sweat proof formulas and infant and children's products. In 2002, we extended our Banana Boat franchise into the indoor tanning market. We also sell a variety of Banana Boat skin care products, including sunless tanning lotion and after-sun moisturizers containing additional ingredients such as vitamin E and aloe vera. Our Sun Care products are a strong number two in the U.S. sun care category with a 22% dollar market share in 2002.

        Retail consumption of our Sun Care products grew 4.9% in 2002 compared to 0.9% for the sun care category. Our results, at retail, benefited from two new products for the 2002 Sun Care season: VitaSkin and Indoor Tanning. VitaSkin combines the benefits of sun protection with a quality skin care product designed for everyday use and our Indoor Tanning product is our first product offering in the indoor tanning segment.

        Since 1995, Banana Boat has been able to consistently grow its share of the sun care category through a strategy of:

        For the 2003 Sun Care season, we continue to bring new products to the market, including two new product lines Banana Boat Suntanicals and Banana Boat Baby Magic. New Suntanicals lotions are enriched with lavender and chamomile botanicals to indulge the skin and senses for a healthy-looking tan. Combining the heritage of two leading

12


brands, Banana Boat Baby Magic sunblocks are clinically proven mild and offer a patented instant protection formula in the lotion that is superior to other baby sunblocks. New in indoor tanning is a Skin Cooling Tan Booster that provides a skin-cooling sensation while tanning. A new extension to the VitaSkin Advanced Sun Protection line is a two-step system that combines an exfoliating scrub with an instant sunless tanner to guarantee a more even, natural-looking tan. In addition, we are introducing a new tanning oil spray with carrot extract. We have also upsized our General Protection SPF 50 and Sport SPF 50 to 8 ounces to provide more value to the consumer. Lastly, we have created more contemporary packaging graphics across the portfolio to simplify the consumer's shopping experience.

        Our Sun Care marketing strategies are directed at the family demographic, where Banana Boat communicates a "fun-in-the-sun for the active wholesome family" image. In addition, the marketing and sales plan for Banana Boat utilizes specialized programs including: sweepstakes, sampling at outdoor events, radio tie-ins and new store openings to provide additional visibility for the brand. Our interactive website, www.bananaboat.com, conveys educational information in a fun, casual manner.

        To supplement our distribution network, we have a direct store delivery ("DSD") distribution team focused in high consumption areas of the U.S. (East and West Coast). With a fleet of more than thirty vans and operators with an in-depth knowledge of our sun care products, the DSD network allows us to build strong retailer relationships, gather marketing intelligence and ensure that our products are properly stocked on retailer shelves.

        Industry convention and the seasonal nature of the sun care business require that manufacturers of Sun Care products provide retailers with the opportunity to return unsold products at the end of the sun care season. To better reflect the impact of potential returns, we provide for estimated returns in our reported operating results as sales are made throughout the year. The level of returns may fluctuate from our estimates due to several factors including weather conditions, customer inventory levels, and competitive conditions (see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies of this Annual Report on Form 10-K).

        In 2002, we initiated a more proactive approach to managing late season shipments to retailers, which negatively impacted our comparable net sales results. The initiative is to better align our shipment patterns to retail consumption patterns during the Sun Care season. As such, we shipped less product during the second half of 2002 than in prior years. We expect to ship more product in the first half of 2003 as a result of the initial implementation of this initiative. We experienced higher than expected Sun Care product returns, in 2002, from the 2001 Sun Care season, which necessitated a change in estimate of our sales return reserve. This adjustment resulted from a few key accounts that unexpectedly returned excess product. We believe our initiatives to reduce Sun Care product returns will result in reducing the overall costs associated with our Sun Care business, as we better align our shipment patterns with consumption patterns for the 2003 Sun Care season.

        Household Products/Personal Grooming—Our Household Products/Personal Grooming business consists of a number of leading and well-recognized brands including our: Woolite rug and upholstery cleaning products, Playtex household gloves, Ogilvie at-home permanents and Binaca breath spray and drops. We also compete in the value-priced end of the toothbrush business with our Tek and Dentax brands of toothbrushes, and in deodorants with our Tussy brand. These products accounted for approximately 48% of our Consumer Products net sales in fiscal 2002, compared to 46% in fiscal 2001 and 45% in fiscal 2000.

        Woolite holds the #2 position in the U.S. rug and upholstery cleaning products category with a 24% dollar market share in 2002. Driving net sales and market share growth in 2002 were two new products: Woolite Instant Power Shot (non-foaming aerosol cleaner designed for quick removal of stains), introduced late in 2001 and Woolite Oxy Deep (oxygen based carpet cleaner designed to remove tough set-in stains) introduced in the third quarter of 2002. These two products accounted for 9.5 dollar market share points in the fourth quarter of 2002 and significantly contributed to our full-year market share and retail consumption gains in 2002.

        With a long-standing reputation for superior quality, durability and value, Playtex Gloves have enjoyed market share leadership since we introduced reusable household latex gloves in the U.S. in 1954. The Playtex brand name is virtually the only well known name in the segment and our Living and Handsaver brands are recognized as the highest

13


quality reusable household gloves in the industry. Playtex is the only major household glove manufacturer with production in the U.S. As demand for disposable household gloves grew, we introduced a line of disposable gloves to leverage the Playtex brand in this category. We offer a complete line of gloves to retailers and have expanded our shelf presence in recent years. In 2002, we lost 2 dollar market share points due to competitive activities and an increase in private label, which is not unusual during tough economic times.

        Our Ogilvie brand is the market leader of the at-home permanents and straighteners category, with a 72% dollar market share in 2002. Retail consumption of at-home permanent products has been declining due to the tendency of consumers to get their hair permed in professional beauty salons. Our strategy is to grow our market leadership position by repositioning the brand to younger consumers and, as category leader, to positively impact the growth of the category as a whole. Since our acquisition of the Ogilvie brand we have successfully launched Ogilvie Straightener, which removes the curl from permed hair, controls the curl from naturally curly hair, and delivers smooth texture to hair. This product is targeted to younger consumers.

        Our Binaca brand of breath fresheners is also a well known brand. It is the leader in the spray & drops segment of the breath fresheners market with a 39% dollar market share in 2002. Our research indicates that Binaca has the highest brand awareness among breath freshener users. Since our acquisition of Binaca in January 1998, we have expanded front-end store placements and launched new products. In 1999, we launched Fast Blast, a non-aerosol spray product, and in 2001 we developed Binaca Power Blasts, a sugar free mint product.

        International/Corporate Sales Division—The International/Corporate Sales Division constituted approximately 19% of our consolidated net sales in fiscal 2002 compared to 18% in 2001 and 17% in 2000. The International/Corporate Sales Division includes:

  Sales to specialty classes of trade in     export sales,
        the United States including wholesale     sales in Puerto Rico,
        clubs, military, convenience stores,     results from our Canadian and Australian
        specialty stores, and telemarketing,           subsidiaries,
          and sales of private label tampons.

The International/Corporate Sales Division sells the same products as are available to our U.S. customers. Sales to specialty classes of trade represented 54% of the total division's net sales in fiscal 2002 compared to 52% in fiscal 2001, and 50% in fiscal 2000.

E. Marketing

        We allocate a significant portion of our revenues to the advertising and promotion of our products. As a result of our adoption of EITF No. 01-9, "Accounting for Consideration Given By a Vendor To a Customer (Including a Reseller of the Vendor's Products)," we reclassified certain previously reported selling, general and administrative expenses to offset net sales in fiscal 2001 and 2000 to conform to our current year presentation (see Note 2 of Notes to Consolidated Financial Statements).

        Our advertising and promotion expenditures for the past three years were (in thousands):

 
  Twelve Months Ended
 
 
  Dec. 28,
2002

  Dec. 29,
2001

  Dec. 30,
2000

 
Total advertising and promotion   $ 83,322   $ 82,832   $ 88,616  
  As a % of net sales     11.6 %   11.4 %   12.1 %

14


        These expenditures are primarily for television, radio and print advertising and production as well as consumer promotions and market research. We believe these expenditures support our brand-building activities and are an investment in the long-term longevity of our brands.

F. Competition

        The markets for our products are highly competitive and they are characterized by the frequent introduction of new products, often accompanied by major advertising and promotional programs. We compete primarily on the basis of product quality, product differentiation and brand name recognition supported by advertising and promotional programs.

        Our competitors consist of a large number of domestic and foreign companies, many of which have significantly greater financial resources and less debt than we do. We believe that the market for consumer-packaged goods is very competitive and may intensify further in the future. Competitive pressures on our products may result from:

  new competitors,     higher spending for advertising and promotion, and
  new product initiatives by competitors,     continued activity in the private label sector.

        Our infant care, feminine care and gloves businesses are particularly competitive. Cups have been challenged by competitors offering less expensive products and new competitors entered the disposable feeding, baby toiletries and pre-moistened towelettes categories in recent years. In 2002, the market share leader in the tampon category introduced a new plastic tampon product supported with extensive advertising and promotions, and our gloves business has weakened due to competitive activities and an increase in private label, which is not unusual during tough economic times.

G. Regulation

        Government regulation has not materially restricted or impeded our operations. Certain of our products are subject to regulation under the Federal Food, Drug and Cosmetic Act and the Fair Packaging and Labeling Act. We are also subject to regulation by the Federal Trade Commission with respect to the content of our advertising, our trade practices and other matters. We are subject to regulation by the United States Food and Drug Administration in connection with our manufacture and sale of tampons.

H. Distribution

        We sell our products using approximately 180 direct sales personnel, independent food brokers and exclusive distributors. Independent brokers supplement the direct sales force in the food class of trade, by providing more effective coverage at the store level. For the twelve months ended December 28, 2002 and December 29, 2001, our net sales in the U.S. were distributed to the following classes of trade:

Class of Trade

  Dec. 28,
2002

  Dec. 29,
2001

 
Mass merchandisers   46 % 44 %
Supermarkets   30 % 31 %
Drug stores   16 % 17 %
Specialty   8 % 8 %
   
 
 
  Total   100 % 100 %
   
 
 

        Our field sales force makes sales presentations at the headquarters or home offices of our customers, where applicable, as well as to individual retail outlets. The sales representatives focus their efforts on selling our products, providing services to our customers and executing programs to ensure sales to the ultimate consumer. Consumer-directed programs include arranging for on-shelf and separate displays and coordinating cooperative advertising participation.

15


        We use four third-party distribution centers to ship the majority of our products to customers. These distribution centers are geographically located to maximize our ability to service our customers.

I. Research and Development

        Our research and development group operates out of a state-of-the-art technical center in Allendale, New Jersey and manufacturing facilities in Dover, Delaware. The Allendale facility was built for us under a fifteen-year lease, which commenced in 1999, with two five-year renewal options. Approximately 80 employees are engaged in our research and development programs, for which expenditures were $15.2 million in fiscal 2002, $13.9 million in fiscal 2001 and $11.6 million in fiscal 2000.

        The primary focus of our research and development group is to design and develop new and improved products that address our customers' wants and needs. In addition, our research and development group provides technology support to both in-house and contract manufacturing and safety and regulatory support to all of our businesses.

J. Trademarks and Patents

        We have proprietary rights to a number of trademarks important to our business, such as: Active Sport, Baby Magic (in United States and Canada), Banana Boat, Binaca, Binky, Blasters, Big Sipster, CoolStraw, Diaper Genie, Dentax, DrinkUp, Drop-Ins, Fast Blast, Gentle Glide, Get On The Boat, Gripster, HandSaver, Heat Therapy, Heavy Traffic, Insulator, LipPops, Most Like Mother, Mr. Bubble, Natural Action, Ogilvie, Oxy Deep, Power Blasts, Power Shot, Precisely Right, QuickStraw, Quik Blok, Safe'N Sure, Silk Glide, SipEase, Slimfits, Soft Comfort, Sooth-A-Caine, Suntanicals, Tub Mate, Tek, Tussy, VentAire, VitaSkin, and Wet Ones. The Playtex and Living trademarks in the United States and Canada are owned by Playtex Marketing. Playtex Marketing is responsible for protecting, exercising quality control over and enforcing the trademarks. Along with Apparel, we have a license from Playtex Marketing for the use of such trademarks in the United States and Canada on a perpetual, royalty-free basis. Apparel's license is for apparel and apparel-related products, and our license is for all other products. In all other countries, Apparel retains title to the Playtex and Living trademarks. We have a perpetual, royalty-free license to use such trademarks for all products other than apparel products in all other countries. We also own a royalty-free license in perpetuity to use the Woolite trademark for rug and upholstery cleaning products in the United States and Canada.

        We also own various patents related to certain products and their method of manufacture, including patents for: cardboard and plastic applicators for tampons, special over-wrap for tampons, baby bottles and nipples, disposable liners and plastic holders for the nurser systems, children's drinking cups, pacifiers, sunscreen formulation, carpet cleaning compositions, various containers for liquid and moist wipes products, including special containers for children's bubble bath.

        The patents expire at varying times, ranging from 2003 to 2022. We also have pending patent applications for various products and methods of manufacture relating to our tampons, infant feeding and sun care businesses. While we consider our patents to be important to our business, we believe that the success of our products is more dependent upon the quality of these products and the effectiveness of our marketing programs. No single patent is material to our business.

K. Raw Materials and Suppliers

        The principal raw materials used in the manufacture of our products are synthetic fibers, resin-based plastics and other chemicals and certain natural materials, all of which are normally readily available. While all raw materials are purchased from outside sources, we are not dependent upon a single supplier in any of our operations for any material essential to our business or not otherwise commercially available to us. We have been able to obtain an adequate supply of raw materials, and no shortage of any materials is currently anticipated.

16


L. Customers and Backlog

        No single customer or affiliated group of customers, except Walmart, accounted for over 10% of our net sales in fiscal 2002, fiscal 2001, and fiscal 2000. Our next three largest customers represented in total approximately 18% of our total consolidated net sales in each of our last three fiscal years (see Note 17 of Notes to Consolidated Financial Statements). In accordance with industry practice, we grant credit to our customers at the time of purchase. In addition, we may grant extended payment terms to new customers and for the initial sales of introductory products and product line extensions. We also may grant extended terms on our Sun Care products due to industry convention and the seasonal nature of this business.

        Our practice is not to accept returned goods unless authorized by management of the sales organization. Returns result primarily from damage and shipping discrepancies. Exceptions to this policy include our Sun Care seasonal returns. We allow customers to return Sun Care products that have not been sold by the end of the Sun Care season, which is normal practice in the sun care industry. Customers are required to pay for the Sun Care product purchased during the season under the required terms. In instances where extended terms are granted on initial Sun Care orders, the terms require a substantial payment be made in the June time frame. We generally receive returns of our Sun Care products from September through March following the summer Sun Care season. In 2002, we initiated a more proactive approach to reduce the expense associated with Sun Care product returns. The initiative is to better align our shipment patterns to retail consumption patterns during the Sun Care season. In addition, we are requesting that retailers return unsold Sun Care product prior to the start of the next Sun Care season. As such, we believe most of our 2002 season Sun Care product returns were processed in fiscal 2002. We reduce our Sun Care sales and increase accrued liabilities for estimated returns, at the same time, based on management's estimates of these returns as a percent of Sun Care products sold. Refunds made to our customers for returned Sun Care products subsequently reduce accrued liabilities (see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies of this Annual Report on Form 10-K for a more complete discussion on our policies regarding Sun Care product returns).

        Because of the short period between order and shipment dates (generally less than one month) for most of our orders, the dollar amount of current backlog is not considered to be a reliable indication of future sales volume.

M. Employees and Labor Relations

        Our worldwide workforce consisted of approximately 1,895 employees as of December 28, 2002, of whom approximately 180 were located outside the United States, primarily in Canada. We believe that our labor relations are satisfactory and no material labor cost increases are anticipated in the near future. Of the United States facilities, only the operation at Watervliet, New York had union representation at December 28, 2002. During 2002, we initiated a process to close our Watervliet, New York facility (see Note 3 of Notes to Consolidated Financial Statements). We expect this process to be completed prior to the expiration, on June 28, 2003, of the current collective bargaining agreement.

N. Environmental

        We believe that we are in substantial compliance with federal, state and local provisions enacted or adopted regulating the discharge of materials hazardous to the environment. There are no significant environmental expenditures anticipated for the current year.

O. Available Information

        We file our annual, quarterly, and current reports, proxy statements, and other documents with the Securities and Exchange Commission (the "SEC") under the Securities and Exchange Act of 1933 and 1934. You may read and copy any materials that we file with the SEC at the SEC's Public Reference Room at 450 Fifth Street, NW, Washington, DC 20549. The SEC also maintains an Internet website that contains our filed reports at www.sec.gov. In addition, we make our filings with the SEC available at the Investors Relations section of our website www.playtexproductsinc.com. You can call our Investor Relations Department at (203) 341-4017 or via email at invrel@playtex.com to request a copy of any of our reports filed with the SEC.

17



Risk Factors

        Our business is subject to certain risks, and we want you to review these risks while you are evaluating our business and our historical results. Please keep in mind, that any of the following risks discussed below and elsewhere in this Annual Report could materially and adversely affect us, our operating results, our financial condition and our projections and beliefs as to our future performance. As such, our results could differ materially from those projected in our forward-looking statements. In addition, the preparation of financial statements in accordance with generally accepted accounting principles requires us to make estimates and assumptions. These estimates and assumptions affect:

        Actual results may vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make as well as assumptions by third parties. The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware. As part of our customary review and reconciliation process, we periodically record adjustments to our accounting estimates. During the second quarter ended June 29, 2002, we recorded additional expenses of $2.0 million to cover higher than expected Sun Care returns from the 2001 Sun Care season. Also, we reduced our reserves for certain advertising and sales promotion programs conducted prior to 2002 by $1.7 million based on the actual costs of these programs versus our original estimates. (see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations— Critical Accounting Policies of this Annual Report on Form 10-K).

We may not enter into a transaction associated with our decision to evaluate strategic alternatives.

        On November 13, 2002, we announced our intention to undertake a process to evaluate strategic alternatives for maximizing shareholder value. The strategic alternatives to be considered include, but are not limited to, business combinations with one or more parties to form a larger personal care and household products company, selling the entire company, divesting one or more lines of business, and acquiring strategic lines of business. There is no assurance this process will result in a transaction.

We have substantial debt, which has risks and restrictions.

        Our indebtedness at December 28, 2002 consists of $380.0 million in fixed rate debt and $447.7 million of variable rate debt.

        We intend to fund our operations, capital expenditures, debt service requirements and repay additional portions of debt principal through cash flow generated from operations, including proceeds from the sale of an undivided fractional interest in our accounts receivables through the Receivables Facility (see Note 9 of Notes to Consolidated Financial Statements in this Annual Report on Form 10-K), and borrowings under the Revolving Credit Facility through fiscal 2007. However, we do not expect to generate sufficient cash flow from operations to make the 2008 and 2009 scheduled principal payments on the Term C Loan, which collectively total $425.3 million. In addition, we do not expect to generate sufficient cash flow from operations to make the $350.0 million scheduled principal payment on the 93/8% Senior Subordinated Notes due June 1, 2011. Accordingly, we will have to refinance our obligations, sell assets or raise equity capital to repay the principal amounts of these obligations. Historically, we have been successful in generating operating cash flows and in obtaining the required refinancing to meet all of our obligations. However, we cannot guarantee that our operating results will continue to be sufficient or that future borrowing facilities will be available for the payment or refinancing of our debt on economically attractive terms.

18


        Our level of debt could have adverse consequences to us, including, but not limited to:

We may incur goodwill and other intangible asset impairment charges.

        Acquisitions recorded as purchases for accounting purposes have resulted, and in the future may result, in the recognition of significant amounts of goodwill and other intangible assets. At December 28, 2002, we had $494.3 million of goodwill and $139.2 million of other intangible assets consisting primarily of trademarks, patents and other intellectual property. We review these intangible assets for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Effective December 30, 2001, the beginning of our 2002 fiscal year, we adopted the provisions of Statement of Financial Accounting Standards ("SFAS") No. 142, "Goodwill and Other Intangible Assets," which changed our accounting for goodwill and other intangible assets with indefinite lives from an amortization method to an impairment only approach. We tested our goodwill, under the methodologies as outlined in SFAS No. 142, for impairment as of December 29, 2001 and March 30, 2002 and determined that none of our goodwill was impaired. We also tested each of our trademarks for impairment by comparing the fair value of each trademark to its carrying value as of December 29, 2001 and March 30, 2002. Based on these impairment tests, we recorded a charge, reported as a cumulative effect of change in accounting principles, of $19.6 million ($12.4 million or $0.19 per diluted share, net of tax benefits) in the first quarter of 2002 (see Note 2 of Notes to Consolidated Financial Statements in this Annual Report on Form 10-K). This charge was to reduce the trademark carrying value of certain non-core brands, primarily Chubs and Diaparene, to their estimated fair value. We are required to test our goodwill and other indefinite lived intangible assets for impairment at least annually and more frequently if events or circumstances indicate a likelihood of impairment. Changes in the fair value of our businesses caused by various factors, some of which may be out of our control, may cause us to take additional impairment charges in the future.

We face significant competition from other consumer products companies.

        The markets for our products are highly competitive and are characterized by the frequent introduction of new products, often accompanied by major advertising and promotional programs. We believe that the market for consumer packaged goods will continue to be highly competitive and that the level of competition may intensify in the future. Our competitors consist of a large number of domestic and foreign companies, a number of which have significantly greater financial resources than we do and are not as highly leveraged as we are. If we are unable to continue to introduce new and innovative products that are attractive to consumers, or are unable to allocate sufficient resources to effectively market and advertise our products so that they achieve widespread market acceptance, we may not be able to compete effectively and our operating results and financial condition will be adversely affected. Our infant care, feminine care and gloves businesses are particularly competitive. Cups have been challenged by competitors offering less expensive products and new competitors entered the disposable feeding, baby toiletries and pre-moistened towelettes categories in recent years. In 2002, the market share leader in the tampon category introduced a new plastic tampon product supported with extensive advertising and promotions and our gloves business has weakened due to competitive activities and an increase in private label. In each case, we are aggressively defending our market share positions, but many of our competitors have greater financial resources than we do.

19


We rely on a few large customers for a significant portion of our sales.

        A few of our customers are material to our business and operations. In fiscal 2002, Walmart our largest customer, represented approximately 25% of our consolidated net sales. Aggregate consolidated net sales to our next three largest customers represented approximately 18% of our total consolidated net sales in fiscal 2002. The loss of sales to a large customer could materially and adversely affect us, our operating results, our financial condition and our projections and beliefs as to our future performance.

We may be adversely affected by the trend towards retail trade consolidation.

        With the growing trend towards retail trade consolidation, we are increasingly dependent upon key retailers whose bargaining strength is growing. We may be negatively affected by changes in the policies of our retail trade customers, such as inventory destocking, limitations on access to shelf space and other conditions.

Sales of some of our products may suffer because of unfavorable weather conditions.

        Our businesses, especially Sun Care, may be negatively impacted by unfavorable weather conditions. In accordance with industry practice, we allow customers to return unsold Sun Care products at the end of the summer and these product returns may be higher in years when the weather is poor. This could adversely affect our business and operating results. In addition, consumption of our Feminine Care and Wet Ones products may be affected by unfavorable weather, although to a lesser extent than the Sun Care business, due primarily to reduced levels of outdoor activities.

Our acquisition strategy is subject to risks and may not be successful.

        We consider the acquisition of other companies engaged in the manufacture and sale of consumer products. At any given time, we may be in various stages of looking at these opportunities. Acquisitions are subject to the negotiation of definitive agreements and to other matters typical in acquisition transactions. There can be no assurance that we will be able to identify desirable acquisition candidates or will be successful in entering into definitive agreements relating to them. Even if definitive agreements are entered into, we cannot assure you that any future acquisition will be completed or that anticipated benefits of the acquisition will be realized. The process of integrating acquired operations into our operations may result in unforeseen operating difficulties, may absorb significant management attention and may require significant financial resources that would otherwise be available for the ongoing development or expansion of our existing operations. Future acquisitions by us could result in the incurrence of additional debt and contingent liabilities, which may have a negative effect on our operating results.

Haas Wheat controls a majority of our Board of Directors and its interests may conflict with yours.

        Haas Wheat & Partners, L.P. and its affiliates together hold approximately 33% of the outstanding shares of our common stock and will likely continue to exercise control over our business by virtue of their voting power with respect to the election of directors. In addition, under our by-laws and agreements among our stockholders, Haas Wheat and its affiliates have the right to approve a majority of the nominations to our board of directors. Haas Wheat and its affiliates may authorize actions that are not in your best interests, and in general, their interests may not be fully aligned with yours.

20



Item 2. Properties

        Our principal executive office is located at 300 Nyala Farms Road, Westport, Connecticut 06880 and is occupied pursuant to a lease, which expires in 2005 with two five-year options to renew. Our principal manufacturing and distribution facilities are located in Dover, Delaware, Sidney and Streetsboro, Ohio, and Arnprior and Malton, Canada. We are in the process of closing our plastic molding facility in Watervliet, New York (see Note 3 of Notes to Consolidated Financial Statements). We maintain a research and development facility in Allendale, New Jersey. This facility is leased for a term of 15 years, expiring in 2013. We operate two facilities in Canada. We own the Arnprior facility, which is primarily a warehouse and assembly operation, and we lease the Malton facility, which is a warehouse and office site. This lease expires in 2004. In fiscal 2002, our average utilization rate of manufacturing capacity was an estimated 65%.

        The following table lists our principal properties as of December 28, 2002, which are located in seven states, Puerto Rico and Canada. The facilities in Arnprior and Malton, Canada and Guaynabo, Puerto Rico are used specifically by the International/Corporate Sales Division. All of the other facilities are shared amongst our three segments.

Facilities Owned

  Number
of
Facilities

  Estimated
Square
Footage

  Manufacturing/Office/Distribution/Warehouse        
    Dover, DE   3   710,000
    Streetsboro, OH   1   189,700
    Watervliet, NY   1   159,600
    Arnprior, Canada   1   91,800
    Sidney, OH   1   54,400

Facilities Leased

 

 

 

 
  Office/Distribution/Warehouse        
    Dover, DE   3   268,900
    Sidney, OH   2   216,800
    Malton, Canada   1   72,800
    Westport, CT   1   72,600
    Allendale, NJ   1   43,500
    Guaynabo, PR   1   15,700
    Orlando, FL   1   10,400
    Spokane, WA   1   8,400


Item 3. Legal Proceedings

        Beginning in 1980, published studies reported a statistical association between tampon use and Toxic Shock Syndrome ("TSS"), a rare, but potentially serious illness. Since these studies, numerous claims have been filed against all tampon manufacturers, a small percentage of which have been litigated to conclusion. The number of TSS claims relating to our tampons has declined substantially over the years. During the mid-1980s, there were approximately 200 pending claims at any one time relating to our tampons. As of the end of February 2003, there were approximately 6 pending claims. Additional claims, however, may be asserted in the future. For TSS claims filed from October 1, 1985 until November 30, 1995, we are self-insured and bear the costs of defending those claims, including settlements and trials. Effective December 1, 1995, we obtained insurance coverage with certain limits in excess of the self-insured retention of $1.0 million per occurrence / $4.0 million in total, for claims occurring on or after December 1, 1995.

        The incidence rate of menstrually associated TSS has declined significantly over the years. The number of confirmed menstrually-related TSS cases peaked in 1980 at 814, with 38 deaths. At that time, the United States Center for Disease Control found that 71% of women who developed the condition had been using a new brand of tampons. That brand of product was removed from the market and The Food and Drug Administration proposed regulations, which required all tampon manufacturers to provide TSS warnings on their labeling. In 1981, the incidence of menstrually-

21


related TSS was reported to be 470, with 13 deaths. It has continued to fall since then. Compared with the 814 menstrual TSS cases in 1980, there were only three confirmed cases in 1998 and six in 1997.

        We believe that there are no claims or litigation pending against us, including the TSS cases, which, individually or in the aggregate, would have a material effect on us. This assessment is based on:

  our experience with TSS cases,     the federally mandated warnings about TSS on and
  our evaluation of the 6 pending claims,           in our tampon packages, and
  the reported decline in the incidence     development of case law upholding the adequacy of
        menstrually associated TSS,           tampon warnings that comply with federally
                mandated TSS warnings.

        We have joined a group of potentially responsible parties with respect to the Kent County Landfill Site in Houston, Delaware, which has been designated a "Superfund" site by the State of Delaware. Based on the information currently available to us, the nature and quantity of material deposited by us and the number of other entities in the group, which are expected to share in the costs and expenses, we do not believe that our costs will be material. We will share equally with Apparel all expenses and costs associated with our involvement with this site.

        We are a defendant in various other legal proceedings, claims and investigations that arise in the normal course of business. In our opinion, the ultimate disposition of these matters, including those described above, will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.


Item 4. Submission of Matters to a Vote of Security Holders

        Not applicable

22



PART II

Item 5. Market for Registrant's Common Equity and Related Stockholder Matters

        We have two classes of authorized stock:

Our common stock is traded on the New York Stock Exchange under the symbol "PYX". No cash dividends have ever been paid on our stock, and we are restricted from paying dividends by the terms of our debt agreements (see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources and Note 8 of Notes to Consolidated Financial Statements included in Item 8. of this Annual Report on Form 10-K).

        The following table lists the high and low sale price per share of our stock during fiscal 2002 and fiscal 2001 as reported by the New York Stock Exchange-Composite Transactions:

 
  First
Quarter

  Second
Quarter

  Third
Quarter

  Fourth
Quarter

Fiscal 2002                        
  High   $ 11.14   $ 14.25   $ 13.04   $ 11.00
  Low   $ 9.60   $ 10.50   $ 8.48   $ 6.95

Fiscal 2001

 

 

 

 

 

 

 

 

 

 

 

 
  High   $ 10.35   $ 11.20   $ 10.80   $ 10.46
  Low   $ 7.93   $ 8.55   $ 9.60   $ 9.30


Item 6. Selected Financial Data

        The information required by this item appears on page F-3 of this Form 10-K.


Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

        The information required by this item appears on pages F-4 to F-17 of this Form 10-K.


Item 7A. Quantitative and Qualitative Disclosure about Market Risk

        We periodically use financial instruments, such as derivatives, to manage the impact of interest rate changes on our variable rate debt and its effect on our earnings and cash flows. Our policies prohibit the use of derivative instruments for the sole purpose of trading for profit on price fluctuations or to enter into contracts, which intentionally increase our underlying interest rate exposure. At December 28, 2002, our total indebtedness consisted of $380.0 million in fixed rate debt and $447.7 million in variable rate debt. We currently are not a party to any financial instruments, such as derivatives, to manage the impact of interest rate changes on our variable rate debt. Based on our interest rate exposure at December 28, 2002, a 1% increase in interest rates would result in an estimated $4.5 million of additional interest expense on an annualized basis (see Note 8 of Notes to Consolidated Financial Statements included in Item 8. of this Annual Report on Form 10-K).

23



Item 8. Financial Statements and Supplementary Data

        The Consolidated Financial Statements and related Notes to Consolidated Financial Statements are filed as part of this Form 10-K and can be found on pages F-18 to F-53. The Independent Auditors' Report, dated January 27, 2003, is filed as part of this Form 10-K and can be found on page F-54. The Report of Management, dated January 27, 2003, is filed as part of this 10-K and can be found on page F-55.


Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

        None


PART III

Item 10. Directors and Executive Officers of the Registrant

Item 11. Executive Compensation

Item 12. Security Ownership of Certain Beneficial Owners and Management

Item 13. Certain Relationships and Related Transactions

        The information called for by these items (except for the information regarding our executive officers) is incorporated by reference to our Proxy Statement for the 2003 Annual Meeting of Stockholders. The information regarding our executive officers called for by Item 401 of Regulation S-K can be found in Item I(b) on pages 5 to 6 of this Form 10-K.


Item 14. Controls and Procedures

(a)
Evaluation of disclosure controls and procedures. Within 90 days prior to the date of this report (the "Evaluation Date"), our Chief Executive Officer and our Executive Vice President and Chief Financial Officer carried out an evaluation of the effectiveness of our "disclosure controls and procedures" (as defined in the Securities Exchange Act of 1934 Rules 13a-14(c) and 15d-14(c). Based on that evaluation, these officers have concluded that as of the Evaluation Date, our disclosure controls and procedures were adequate and effective to ensure that material information relating to the Company would be made known to them, particularly during the period in which this Annual Report on Form 10-K was being prepared.

(b)
Changes in internal controls. There have been no significant changes in our internal controls or in other factors that could significantly affect our internal controls after the date of their evaluation, nor any significant deficiencies or material weaknesses in such internal controls requiring corrective actions. As a result, no corrective actions were taken.

        It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the systems are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all future conditions, regardless of how remote.

24



PART IV

Item 15. Exhibits, Financial Statement Schedule and Reports on Form 8-K

        (a)    Financial Statements

        (b)  Reports on Form 8-K

        On November 13, 2002, we filed a current report on Form 8-K with the Securities and Exchange Commission pursuant to Item 5 of that Form. Pursuant to Item 5, we announced our intent to undertake a process to evaluate strategic alternatives for maximizing shareholder value. The strategic alternatives to be considered include, but are not limited to, business combinations with one or more parties to form a larger personal care and household products company, selling the entire company, divesting one or more lines of business, and acquiring strategic lines of business.

25



PLAYTEX PRODUCTS, INC.

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
Twelve Months Ended December 28, 2002, December 29, 2001, and December 30, 2000
(In thousands)

Description

  Balance at
Beginning
of Period

  Additions
Charged to
Income

  Write-off
  Balance
at End
of Period

 
December 30, 2000                          
  Allowance for doubtful accounts   $ (2,292 ) $ (346 ) $ 401   $ (2,237 )
December 29, 2001                          
  Allowance for doubtful accounts(1)   $ (2,237 ) $ (1,771 ) $ 1,943   $ (2,065 )
December 28, 2002                          
  Allowance for doubtful accounts(1)   $ (2,065 ) $ (1,053 ) $ 1,844   $ (1,274 )

(1)
Includes valuation and qualifying accounts of the Company's wholly-owned special purpose subsidiary used in conjunction with the Receivable Facility of $789 in 2001 and $302 in 2002. (see Note 9 of Notes to Consolidated Financial Statements included in Item 8. of this Annual Report on Form 10-K).

26



SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    PLAYTEX PRODUCTS, INC.

 

 

By:

 

/S/ MICHAEL R. GALLAGHER

Michael R. Gallagher
Chief Executive Officer

March 27, 2003

 

 

 

 

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated this 27th day of March, 2003.

Signatures

  Title

/S/ ROBERT B. HAAS

Robert B. Haas

 

Chairman of the Board and Director

/S/ MICHAEL R. GALLAGHER

Michael R. Gallagher

 

Chief Executive Officer and Director (Principal Executive Officer)

/S/ GLENN A. FORBES

Glenn A. Forbes

 

Executive Vice President, Chief Financial Officer and Director (Principal Financial and Accounting Officer)

/S/ RICHARD C. BLUM

Richard C. Blum

 

Director

/S/ MICHAEL R. EISENSON

Michael R. Eisenson

 

Director

/S/ R. JEFFREY HARRIS

R. Jeffrey Harris

 

Director

/S/ C. ANN MERRIFIELD

C. Ann Merrifield

 

Director

/S/ SUSAN R. NOWAKOWSKI

Susan R. Nowakowski

 

Director

/S/ JOHN C. WALKER

John C. Walker

 

Director

/S/ WYCHE H. WALTON

Wyche H. Walton

 

Director

/S/ DOUGLAS D. WHEAT

Douglas D. Wheat

 

Director

27



PLAYTEX PRODUCTS, INC.
CERTIFICATIONS

I, Michael R. Gallagher, Chief Executive Officer, certify that:

1.
I have reviewed this Annual Report on Form 10-K of Playtex Products, Inc. for the year-ended December 28, 2002;

2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3.
Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4.
The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a.
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

b.
evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the "Evaluation Date"); and

c.
presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5.
The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a.
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and
6.
The registrant's other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date:   March 27, 2003
      By:   /S/ MICHAEL R. GALLAGHER
Michael R. Gallagher
Chief Executive Officer
(Principal Executive Officer)

28



PLAYTEX PRODUCTS, INC.
CERTIFICATIONS

I, Glenn A. Forbes, Executive Vice President and Chief Financial Officer, certify that:

1.
I have reviewed this Annual Report on Form 10-K of Playtex Products, Inc. for the year-ended December 28, 2002;

2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3.
Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4.
The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a.
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

b.
evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the "Evaluation Date"); and

c.
presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5.
The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a.
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and
6.
The registrant's other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date:   March 27, 2003
      By:   /S/ GLENN A. FORBES
Glenn A. Forbes
Executive Vice President and
Chief Financial Officer
(Principal Financial and Accounting Officer)

29



PLATEX PRODUCTS, INC.

2002 ANNUAL REPORT TO STOCKHOLDERS


PLATEX PRODUCTS, INC.
2002 ANNUAL REPORT TO STOCKHOLDERS

INDEX

 
  PAGE(S)
PART I—FINANCIAL INFORMATION    

Selected Financial Data

 

F-3

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

F-4 to F-17

Consolidated Financial Statements

 

F-18 to F-21

Notes to Consolidated Financial Statements

 

F-22 to F-53

PART II—OTHER INFORMATION

 

 

Independent Auditors' Report

 

F-54

Report of Management

 

F-55

Other Information

 

F-56 to F-57

F-2



PLAYTEX PRODUCTS, INC.

SELECTED FINANCIAL DATA

(In thousands, except per share data)

 
  Twelve Months Ended(1)
 
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

  December 25,
1999

  December 26,
1998

 
Earnings Statement Data:                                
  Net sales   $ 719,087   $ 723,518   $ 733,363   $ 695,536   $ 588,418  
  Gross profit     390,654     389,711     398,380     385,615     328,454  
  Operating expenses, excluding amortization of intangibles     248,219 (2)   233,660     228,093     209,322     179,684  
  Amortization of intangibles     928 (3)   22,060     22,350     21,064     17,336  
  Operating earnings     141,507     133,991     147,937     155,229     131,434  
  Interest expense, net     59,543     75,861     84,884     78,961     71,518  
  Net earnings   $ 48,904 (4) $ 11,545 (5) $ 35,544   $ 44,071   $ 34,230  
  Net earnings per share:                                
    Basic   $ 0.80   $ 0.19   $ 0.58   $ 0.73   $ 0.58  
    Diluted   $ 0.79   $ 0.19   $ 0.58   $ 0.72   $ 0.57  
  Net earnings before extraordinary loss and cumulative effect of change in accounting principle   $ 65,062   $ 30,881   $ 35,544   $ 44,071   $ 34,230  
  Net earnings per share before extraordinary loss and cumulative effect of change in accounting principle:                                
    Basic   $ 1.06   $ 0.51   $ 0.58   $ 0.73   $ 0.58  
    Diluted   $ 1.04   $ 0.51   $ 0.58   $ 0.72   $ 0.57  
  Weighted average common shares and equivalent common shares outstanding:                                
    Basic     61,148     61,007     60,824     60,481     59,486  
    Diluted     63,948     61,115     62,585     62,553     60,411  
Balance Sheet Data (at period end):                                
  Working capital   $ 114,926   $ 107,780   $ 74,233   $ 92,006   $ 78,548  
  Total assets     1,078,187     1,105,172     1,139,384     1,148,652     899,221  
  Total long-term debt, excluding due to related party     827,750     888,800     931,563     987,876     811,750  
  Stockholders' equity (deficit)   $ 5,533   $ (44,570 ) $ (56,063 ) $ (94,868 ) $ (140,975 )

(1)
Our fiscal year end is on the last Saturday in December nearest to December 31 and, as a result, a fifty-third week is added every 6 or 7 years. Fiscal 2000 was a fifty-three week year. All other years presented are fifty-two week years.

(2)
Includes a restructuring and asset impairment charge of $7.6 million as a result of the closing of our Watervliet, New York plastic molding facility (see Note 3 of Notes to Consolidated Financial Statements).

(3)
Amortization of intangible assets with indefinite lives was discontinued, as a result of our implementation of Statement of Financial Accounting Standards No. 142 "Goodwill and Other Intangible Assets" ("SFAS No. 142") (see Note 2 of Notes to Consolidated Financial Statements).

(4)
Includes an extraordinary loss of $3.7 million, net of $2.2 million of income tax benefits, as a result of amending our senior secured credit facility (see Notes 8 and 10 of Notes to Consolidated Financial Statements) and cumulative effect of change in accounting principle of $12.4 million, net of $7.1 million of income tax benefits, as a result of our implementation of SFAS No. 142 (see Note 2 of Notes to Consolidated Financial Statements). Offsetting these charges, in part, is a tax benefit of $14.3 million relating to new tax regulations associated with loss disallowance rules (see Note 12 of Notes to Consolidated Financial Statements).

(5)
Includes an extraordinary loss of $19.3 million, net of $12.8 million of income tax benefits, as a result of the refinancing of our senior indebtedness (see Notes 8 and 10 of Notes to Consolidated Financial Statements).

F-3



PLAYTEX PRODUCTS, INC.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

        The following discussion and analysis of our financial condition and results of operations should be read together with our audited consolidated financial statements and notes, presented on pages F-18 through F-53.

Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the Private Securities Litigation Reform Act of 1995

        This document includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future results. When we use words in this document such as "anticipates," "intends," "plans," "believes," "estimates," "expects," and similar expressions we do so to identify forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements. These forward-looking statements are affected by risks, uncertainties, and assumptions that we make, including, among other things, the Risk Factors that are listed in Part I, Item 1 of this Annual Report on Form 10-K and:

  price and product changes,     impact of weather conditions, especially
  promotional activity by competitors,           on Sun Care product sales,
  the loss or bankruptcy of a significant customer,     our level of debt and its restrictive covenants,
  capacity limitations,     interest rate fluctuations,
  the difficulties of integrating acquisitions,     future cash flows,
  raw material and manufacturing costs,     dependence on key employees, and
  adverse publicity and product liability claims,     highly competitive nature of consumer products
    business.

        You should keep in mind that any forward-looking statement made by us in this document, or elsewhere, speaks only as of the date on which we make it. New risks and uncertainties come up from time to time, and it's impossible for us to predict these events or how they may affect us. In light of these risks and uncertainties, you should keep in mind that any forward-looking statements made in this report or elsewhere might not occur.

        On November 13, 2002, we announced our intent to undertake a process to evaluate strategic alternatives for maximizing shareholder value. The strategic alternatives to be considered include, but are not limited to, business combinations with one or more parties to form a larger personal care and household products company, selling the entire company, divesting one or more lines of business, and acquiring strategic lines of business. We cannot assure you that this process will result in a transaction.

        In addition, the preparation of financial statements in accordance with generally accepted accounting principles requires us to make estimates and assumptions. These estimates and assumptions affect:

        Actual results may vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make as well as assumptions by third parties. The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware (see Management's Discussion and Analysis—Critical Accounting Policies). As part of our customary review and reconciliation process, we periodically record adjustments to our accounting estimates. During the second quarter ended June 29, 2002, we recorded additional expenses of $2.0 million to cover higher than expected Sun Care returns from the 2001 Sun Care season. Also, we reduced our reserves for certain advertising and sales promotion programs conducted prior to 2002 by $1.7 million based on the actual costs of these programs versus our original estimates.

F-4


General

        We are organized in three divisions, which are categorized as business segments in accordance with generally accepted accounting principles.

        Our Personal Products Division accounted for 59% of our 2002 consolidated net sales. Our Personal Products Division includes Infant Care and Feminine Care products sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Infant Care product category includes the following brands:

Infant Feeding Products   Other Infant Care Products
  Playtex disposable nurser system     Diaper Genie diaper disposal system
  Playtex cups and mealtime products     Wet Ones towelettes
  Playtex reusable hard bottles     Baby Magic infant toiletries
  Playtex pacifiers     Baby Magic baby wipes, and
          Mr. Bubble children's bubble bath

        The Feminine Care product category includes a wide range of plastic and cardboard applicator tampons, as well as complementary products, marketed under such brand names as:

Tampons   Complementary Products
  Playtex Gentle Glide,     Playtex Personal Cleansing Cloths
  Playtex Portables,           for use in feminine hygiene, and
  Playtex Slimfits,     Playtex Heat Therapy patch to
  Playtex Silk Glide,           alleviate discomfort associated
                with menstrual pain.

        Our Consumer Products Division accounted for 22% of our 2002 consolidated net sales. Our Consumer Products Division includes a number of leading and well-recognized brands in niche categories sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Consumer Products Division includes the following brands:

  Banana Boat Sun Care products     Binaca breath spray and drops
  Woolite rug and upholstery cleaning products     Tussy deodorant
  Playtex Gloves     Dentax oral care products, and
  Ogilvie at-home permanents     Tek toothbrushes

        Our International/Corporate Sales Division accounted for 19% of our 2002 consolidated net sales and includes:

  Sales to specialty classes of trade in     Export sales
        the United States including: warehouse     Sales in Puerto Rico
        clubs, military, convenience stores,     Results from our Canadian and Australian
        specialty stores, and telemarketing           subsidiaries, and
          Sales of private label tampons

        The International/Corporate Sales Division sells the same products as are available to our U.S. customers. Sales to the specialty classes of trade in the United States represented 54% of the division's consolidated net sales in fiscal 2002, up from 52% in fiscal 2001 and 50% in fiscal 2000.

F-5


Results of Operations

        Our net sales for each of the past three fiscal years 2002, 2001, and 2000 are provided based on our divisional structure (dollars in millions):

 
   
  Twelve Months Ended
Product Line

  2002 Principal Brand Names
  December 28,
2002

  December 29,
2001

  December 30,
2000

Personal Products Division:                      
  Infant Care   Playtex, Wet Ones, Mr. Bubble, Diaper Genie, and Baby Magic   $ 226.1   $ 231.2   $ 243.9
  Feminine Care   Playtex     196.1     190.6     189.4
       
 
 
    Total Personal Products Division         422.2     421.8     433.3
Consumer Products Division:                      
  Sun Care   Banana Boat     83.3     93.0     95.5
  Household Products/Personal Grooming   Playtex, Woolite, Ogilvie, Binaca, Tussy, Tek, and Dentax     76.5     78.9     78.9
       
 
 
    Total Consumer Products Division         159.8     171.9     174.4
International/Corporate Sales Division         137.1     129.8     125.7
       
 
 
      Total       $ 719.1   $ 723.5   $ 733.4
       
 
 

        We evaluate division performance based on their product contribution excluding general corporate allocations. Product contribution is defined as gross profit less advertising and sales promotion expenses. All other operating expenses are managed at a corporate level and are not used by us to evaluate division results. We do not segregate assets, amortization, capital expenditures, certain corporate and administrative costs, and interest income and interest expense when evaluating division performance.

        The following discussion presents a consolidated view of our results and, where appropriate, also provides insight to key indicators of division performance. Our results for the years ended December 28, 2002 and December 29, 2001 are for fifty-two week periods and our results for the year ended December 30, 2000 are for a fifty-three week period. Our fiscal year end is on the last Saturday in December nearest to December 31 and, as a result, a fifty-third week is added every 6 or 7 years.

        As a result of our adoption of the Emerging Issues Task Force ("EITF") of the Financial Accounting Standards Board ("FASB") Issue No. 00-14, "Accounting for Certain Sales Incentives" and Issue No. 00-25, "Vendor Income Statement Characterization of Consideration from a Vendor to a Reseller," both of which were codified in November of 2001 with related issues into EITF No. 01-09, "Accounting for Consideration Given By a Vendor To a Customer (Including a Reseller of the Vendor's Products)," we reclassified certain previously reported selling, general and administrative expenses to offset net sales in fiscal 2001 and 2000 to conform to our current year presentation. These reclassifications reduced both our net sales and selling, general and administrative expenses by equal and offsetting amounts and had no impact on our reported operating earnings, net income, or earnings per share (see Note 2 of Notes to Consolidated Financial Statements). We also reclassified certain expenses from the cost of sales line item to the selling, general and administrative line item to better reflect the nature of these expenses. We reclassified all prior year data to conform to our current year presentation.

        We also adopted, on December 30, 2001, Statement of Financial Accounting Standards ("SFAS") No. 141, "Business Combinations," and SFAS No. 142, "Goodwill and Other Intangible Assets." As a result of the adoption of SFAS No. 142, we ceased the amortization of: (a) all of our remaining goodwill balance and (b) trademarks that are determined to have indefinite lives. Had we accounted for goodwill and other intangible assets under SFAS No. 142 for fiscals 2001 and 2000, our reported net earnings and earnings per share would have increased $18.1 million or $0.29 per diluted share in each year. Also in connection with the new requirements set forth in SFAS No. 142, we performed impairment tests on our indefinite-lived intangible assets based on a fair value concept. As a result of this testing, in the first quarter of 2002, we recorded an after tax impairment in trademarks for certain non-core businesses of $12.4 million,

F-6


net of $7.1 million of tax benefits, or $0.20 per diluted share (see Note 2 of Notes to Consolidated Financial Statements). The adoption of SFAS No. 141 had no impact on our earnings.

        On March 7, 2002, the U.S. Treasury issued new regulations that replace the loss disallowance rules applicable to the sale of stock of a subsidiary member of a consolidated tax group. These regulations permit us to utilize a previously disallowed $135.1 million tax capital loss that resulted from the sale of Playtex Beauty Care Inc., during fiscal 1999. We anticipate utilizing $40.0 million of the capital loss to offset a capital gain, in fiscal 2003, related to the retirement of our related party notes, which come due on December 15, 2003 (see Notes 7, 11 and 12 of Notes to Consolidated Financial Statements). Accordingly, in the first quarter of 2002, we recorded a tax benefit of $14.3 million. The impact, in fiscal 2002, was $0.22 on a diluted share basis.

        All references to market share and market share data are for comparable 52-week periods and represent our percentage of the total U.S. dollar volume of products purchased by consumers in the applicable category (dollar market share, or retail consumption). This information is provided to us from the ACNielsen Company ("ACNielsen") and is subject to revisions. During 2001, Wal-Mart Stores, Inc. ("Walmart"), ceased providing scanner/consumption data to third parties. As a result, ACNielsen restated consumption and market share data for fiscals 2001 and 2000 to exclude Walmart consumption data.

Twelve Months Ended December 28, 2002 Compared To
    Twelve Months Ended December 29, 2001

Consolidated Net Sales—Our consolidated net sales decreased $4.4 million, to $719.1 million in 2002 as a result of lower Sun Care, Infant Care, and Personal Grooming net sales offset, in part, by gains in Feminine Care and Household Products. Our results benefited from a number of new products including Playtex Heat Therapy and Personal Cleansing Cloths, the Insulator cup, Baby Magic Calming Milk, and Woolite Oxy Deep.

Personal Products Division—Net sales increased $0.4 million, to $422.2 million in 2002.

F-7


Consumer Products Division—Net sales decreased $12.1 million, or 7%, to $159.8 million in 2002.

International/Corporate Sales Division—Net sales increased $7.3 million, or 6%, to $137.1 million in 2002. A significant portion of this increase was due to higher Sun Care net sales to the specialty classes of trade, primarily club stores. Net sales in the U.S. specialty classes of trade increased 10% in 2002 and our international net sales were essentially flat compared to 2001. We believe the sales growth in the U.S. specialty classes of trade was due primarily to the increased focus on these distribution channels.

F-8


Consolidated Gross Profit—Our consolidated gross profit increased $0.9 million to $390.7 million in 2002. As a percent of net sales, gross profit increased 0.4 percentage points, to 54.3% in 2002. The increase in gross profit and gross profit as a percent of net sales was due primarily to the mix of products sold and favorable product cost.

Consolidated Product Contribution—Our consolidated product contribution increased $0.5 million to $307.3 million in 2002. As a percent of net sales, product contribution increased 0.3 percentage points to 42.7% in 2002. The increase in product contribution and product contribution as a percent of net sales was due to higher gross profit offset, in part, by higher advertising and sales promotion expenses.

Consolidated Operating Earnings—Our consolidated operating earnings increased $7.5 million, or 6%, to $141.5 million in 2002. The increase in operating earnings was a result of a reduction of $21.1 million of amortization expense, in 2002, associated with our implementation of SFAS No. 142. In accordance with SFAS No. 142, we stopped the amortization of goodwill and other intangible assets with indefinite lives on December 29, 2001, the beginning of our 2002 fiscal year (see Note 2 of Notes to Financial Statements). Assuming SFAS No. 142 was implemented on December 31, 2000, the start of our fiscal year 2001, our operating earnings would have decreased $13.6 million, or 10.2% compared to 2001. This decrease is the result of a restructuring and asset impairment charge of $7.6 million related to the closing of our Watervliet, New York plastic molding facility (see Note 3 of Notes to Consolidated Financial Statements) and a 3% increase in our selling, general and administrative expenses.

Consolidated Interest Expense, Net—Our consolidated interest expense decreased $16.3 million, or 22%, to $59.5 million in 2002. The decrease in interest expense was due to the combined impact of:

F-9


Consolidated Other Expenses—Our consolidated other expenses increased $0.6 million, or 26%, to $2.7 million in 2002. In late May 2001, we entered into a receivables purchase agreement with a third party as part of the refinancing transaction (see Notes 8 and 9 of Notes to Consolidated Financial Statements). The amount charged to other expenses represents the discount offered to the third party on the sale of receivables and the amortization of deferred financing costs associated with the formation of the Receivables Facility. The increase in 2002 was due to having the Receivables Facility available to us for the full fiscal year.

Consolidated Income Taxes—Our consolidated income taxes decreased $10.9 million, or 43%, to $14.2 million in 2002. As a percent of pre-tax earnings, our effective tax rate decreased 26.9 percentage points to 18.0% of earnings before income taxes, extraordinary loss and cumulative effect of change in accounting principle. In the first quarter of 2002, we recorded a tax benefit of $14.3 million, or $0.22 per diluted share, due to new regulations issued by the U.S. Treasury on March 7, 2002 (see Note 12 of Notes to Consolidated Financial Statements). The new regulations permit us to partially utilize a previously disallowed capital loss on the sale of Playtex Beauty Care Inc., which we sold during fiscal 1999. We expect our effective tax rate, in 2003, to be approximately 37% of earnings before income taxes. This effective tax rate is below our historical average tax rate, because we ceased the amortization of goodwill and intangible assets with indefinite lives as a result of our adoption of SFAS No. 142 in 2002 (see Note 2 of Notes to Consolidated Financial Statements). A large portion of the goodwill amortization we recorded in previous periods was non-deductible for tax purposes, which resulted in a higher effective tax rate.

Extraordinary Loss—On May 29, 2002, we amended our Credit Facility and issued a new $450.0 million Term C Loan and, together with $21.8 million of cash, we repaid in full our outstanding obligations under our Term A Loan and Term B Loan, which collectively totaled $471.8 million (see Note 8 of Notes to Consolidated Financial Statements). We recorded an extraordinary loss during the second quarter ended June 29, 2002 of $3.7 million, net of income tax benefits of $2.2 million, or $0.06 per diluted share, associated with the write-off of unamortized deferred financing costs relating to our Term A Loan and Term B Loan.

        In the second quarter of 2001, we recorded an extraordinary loss of $19.3 million, net of income tax benefits of $12.8 million, or $0.32 per diluted share, as a result of the refinancing of our senior indebtedness (see Note 8 of Notes to Consolidated Financial Statements). This extraordinary loss included cash provisions for call premiums on our retired fixed rate indebtedness, a non-cash provision for the write-off of unamortized deferred financing costs, fees for two interest rate swap agreements related to our prior credit facility and duplicative net interest expense during the period between extinguishment and redemption of the fixed rate indebtedness.

Cumulative Effect of Change in Accounting Principle—In connection with the adoption of SFAS No. 142 (see Note 2 of Notes to Consolidated Financial Statements), we performed impairment tests on our indefinite-lived intangible assets based on a fair value concept as prescribed by this new accounting rule. We recorded an after tax charge of $12.4 million, net of income tax benefits of $7.1 million, or $0.19 per diluted share, as a cumulative effect of change in accounting principle as a result of the new impairment testing methodology. The impairment was related to certain trademarks acquired in our acquisition of Personal Care Holdings, Inc., which we acquired on January 28, 1998. We determined the fair values of all of our trademarks at December 29, 2001 and compared them with their carrying values. The trademarks impacted by this write-off were in our non-core brands including: Chubs, Diaparene, Tussy, Dorothy Gray, and Better Off.

F-10


Twelve Months Ended December 29, 2001 Compared To
    Twelve Months Ended December 30, 2000

Consolidated Net Sales—Our consolidated net sales decreased $9.8 million, to $723.5 million in 2001. Fiscal 2001 was a challenging year for us, as a difficult economic environment and competitive issues, primarily in Infant Care, negatively impacted our results.

Personal Products Division—Net sales decreased $11.5 million, or 3%, to $421.8 million in 2001.

Consumer Products Division—Net sales decreased $2.5 million, or 1%, to $171.9 million in 2001.

F-11


International/Corporate Sales Division—Net sales increased $4.1 million, or 3%, to $129.8 million in 2001. The increase was due primarily to higher net sales in the specialty classes of trade. Net sales in the U.S. specialty classes of trade were $67.5 million in 2001, an increase of 8% compared to 2000. We believe this growth was due primarily to the increased focus on these distribution channels. Our international net sales including our Canadian subsidiary and Puerto Rico were $62.3 million in 2001, down $0.8 million compared to 2000.

Consolidated Gross Profit—Our consolidated gross profit decreased $8.7 million, or 2%, to $389.7 million in 2001. As a percent of net sales, gross profit decreased 0.5 percentage points, to 53.9% in 2001. The decrease in gross profit and gross profit as a percent of net sales was due primarily to our lower net sales and higher bad debt provisions.

Consolidated Product Contribution—Our consolidated product contribution decreased $2.9 million, or 1%, to $306.9 million in 2001. As a percent of net sales, product contribution increased 0.2 percentage points to 42.4% in 2001. The decrease in product contribution was due primarily to lower gross margins offset, in part, by lower overall advertising and sales promotion expenses.

Consolidated Operating Earnings—Our consolidated operating earnings decreased $13.9 million, or 9%, to $134.0 million in 2001. The decrease in operating earnings was the result of lower consolidated net sales, gross profit, and product contribution as discussed and higher selling, general and administrative expenses reflecting normal salary increases and support of new product initiatives.

Consolidated Interest Expense—Our consolidated interest expense decreased $9.0 million, or 11%, to $75.9 million in 2001. The decrease in interest expense was due to the combined impact of:

Consolidated Other Expenses—Our consolidated other expenses were $2.1 million in 2001. During the second quarter of 2001, we entered into a receivables purchase agreement with a third party as part of the refinancing transaction (see Notes 8 and 9 of Notes to Consolidated Financial Statements). The amount charged to other expenses represents the discount offered to the third party on the sale of receivables and the amortization of deferred financing costs associated with the formation of the Receivables Facility.

F-12


Consolidated Income Taxes—Our consolidated income taxes decreased $2.4 million, or 9%, to $25.1 million in 2001. As a percent of pre-tax earnings, our effective tax rate before extraordinary loss increased 1.3 percentage points to 44.9% of pre-tax earnings in 2001. Our effective tax rate increases, as the portion of goodwill amortization that is non-deductible for tax purposes becomes a larger portion of operating earnings.

Consolidated Extraordinary Loss—In the second quarter of 2001, we recorded an extraordinary loss of $19.3 million, net of income tax benefits of $12.8 million, or $0.32 per diluted share, as a result of the refinancing of our senior indebtedness (see Note 8 of Notes to Consolidated Financial Statements). The extraordinary loss included cash provisions for call premiums on our 9% Senior Subordinated Notes due 2003 (the "9% Notes") and our 87/8% Senior Notes due 2004 (the "87/8% Notes"), termination fees for two interest rate swap agreements related to our prior credit facility, and duplicative net interest expense during the period between extinguishment and redemption of the 9% Notes and 87/8% Notes. The extraordinary loss also contained a non-cash provision for the write-off of unamortized deferred financing costs related to the 9% Notes, 87/8% Notes and the prior credit agreement.

Liquidity and Capital Resources

        On November 13, 2002, we announced our intent to undertake a process to evaluate certain strategic alternatives including, but not limited to, business combinations, selling the entire company, divesting one or more lines of business, and acquiring strategic lines of business. We cannot assure you that this process will result in a transaction. Also certain scenarios may require us to seek additional debt or equity financing, in certain situations, in connection with some of the strategic alternatives available to us. As we cannot assure you that such financing will be available to us, our ability to execute certain strategic alternatives may be restricted.

        One of our major corporate objectives has been to reduce our outstanding indebtedness and lower our borrowing costs. We reduced our indebtedness by: $61.0 million in fiscal 2002, $42.8 million in fiscal 2001, and $56.3 million in fiscal 2000. Highlights of this strategy include:

F-13


        At December 28, 2002, long-term debt (including current portion but excluding obligations due to related party) was $827.8 million compared to $888.8 million at December 29, 2001. During 2002, we redeemed $20.0 million of our 6% Convertible Notes and repaid $40.0 million of variable rate debt. Our remaining scheduled principal repayment obligations are (excluding amounts due to related party):

  $4.5 million in 2003,     $4.5 million in 2006, and
  $34.5 million in 2004,     $779.8 million thereafter.
  $4.5 million in 2005,        

        In the event that we have excess cash flow, as defined in our credit agreement, we may, within 90 days of each year-end, be required to: make either mandatory debt repayments on the Term C Loan equal to the amount of the excess cash flow, as defined, or make deposits into an excess cash flow account which will be used to redeem our 6% Convertible Notes. In March of 2003, we deposited $19.1 million into the excess cash flow account and we intend to use these funds to repay a portion of our 6% Convertible Notes in April of 2003.

        Our Revolving Credit Facility provides for borrowings of up to $125.0 million and matures on May 22, 2007. At December 28, 2002, we had $121.6 million available to borrow under the Revolving Credit Facility, net of outstanding letters of credit. At December 28, 2002, the undivided fractional interest sold by Playtex A/R LLC to a third party commercial paper conduit under the Receivables Facility was $39.0 million.

        The terms of the Credit Facility require us to meet certain financial tests and also include conditions or restrictions on:

  new indebtedness and liens,     dividends and other distributions, and
  major acquisitions or mergers,     the application of excess cash flow.
  capital expenditures and asset sales,        

        At December 28, 2002, our working capital (current assets net of current liabilities) increased $7.1 million to $114.9 million compared to $107.8 million at December 29, 2001.

        Our net cash flows from operations decreased $49.0 million, to $77.9 million in fiscal 2002. Our net cash flows from operations were very high at the end of 2001 due to the initial benefit realized on the establishment of the Receivables Facility. In fiscal 2001, we increased our cash flow derived from working capital by $56.5 million by selling an undivided fractional interest in our Accounts Receivable to a third party via our Receivables Facility. Excluding the sales of receivables in 2001 and 2002 via our Receivables Facility, our net cash flows from operations would have increased by $25.0 million in fiscal 2002 compared to 2001. We used the cash flows generated from operations, over the last three fiscal years, to reduce our outstanding indebtedness, as noted above, to fund purchases of capital assets and intangible assets and to pay fees related to our debt refinancing efforts.

        We intend to fund our operations, capital expenditures and debt service requirements through cash flow generated from operations, including proceeds from the Receivables Facility, and borrowings under the Revolving Credit

F-14


Facility through fiscal 2007. However, we do not expect to generate sufficient cash flow from operations to pay in full the 2008 and 2009 scheduled principal payments on the Term C Loan, which collectively total $425.3 million. In addition, we do not expect to generate sufficient cash flow from operations to fund the $350.0 million scheduled principal payment on the 93/8% Notes due in fiscal 2011. Accordingly, we will have to refinance our obligations, sell assets or raise equity capital to repay the principal amounts of these obligations. Historically, our cash flows from operations and refinancing activities have enabled us to meet all of our obligations. However, we cannot guarantee that our operating results will continue to be sufficient or that future-borrowing facilities will be available for the payment or refinancing of our debt on economically attractive terms.

        Capital expenditures for equipment and facility improvements were $16.4 million in 2002. These expenditures were used primarily to support new products and product improvements, expand capacity in key product areas, upgrade production equipment, invest in new technologies, and improve our facilities. We anticipate 2003 capital expenditures to be approximately $25.0 million.

Off Balance Sheet Arrangements and Other Commitments

        On occasion we enter into certain off-balance sheet arrangements and other commitments with unaffiliated third parties. At December 28, 2002, we had two-off balance sheet arrangements.

        On May 22, 2001, we entered into the Receivables Facility through a wholly owned, special purpose bankruptcy remote subsidiary of ours, Playtex A/R LLC (see Note 9 of Notes to Consolidated Financial Statements). Through the Receivables Facility, we sell on a continuous basis to Playtex A/R LLC substantially all of our domestic customers' trade invoices that we generate. Playtex A/R LLC sells to a third-party commercial paper conduit (the "Conduit") an undivided fractional ownership interest in these trade accounts receivable. We believe the Receivables Facility is beneficial to us as: (1) we convert trade receivables to cash faster, and (2) although we sell our invoices to Playtex A/R LLC at a discount and pay fees to the Conduit, these expenses are lower than our borrowing costs under the Credit Facility. We sold $39.0 million of undivided fractional interest in our receivables, at December 28, 2002, through the Receivables Facility.

        We also enter into operating leases with unaffiliated third parties. These leases are primarily for buildings, manufacturing equipment, automobiles and information technology equipment. At December 28, 2002, we had in aggregate $32.1 million of committed expenses associated with operating leases that are not reflected on our Consolidated Balance Sheet as a liability, in accordance with generally accepted accounting principles (see Note 15 of Notes to Consolidated Financial Statements). We believe operating leases are beneficial to us by allowing us to match the cost of the asset with the benefits derived from it. Operating leases also provide us with greater flexibility in regards to technological change, minimizing the risk of our productive assets becoming obsolete.

Critical Accounting Policies

        The preparation of financial statements in accordance with generally accepted accounting principles requires us to make estimates and assumptions. These estimates and assumptions affect:

        Actual results could vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make as well as assumptions by third parties.

        The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware.

F-15


Recently Issued Accounting Standards

        In July 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations ("SFAS No. 143"). SFAS No. 143 requires that asset retirement obligations that are identifiable upon acquisition and construction, and during the operating life of a long-lived asset be recorded as a liability using the present value of the estimated cash flows. A corresponding amount would be capitalized as part of the assets carrying amount and amortized to expense over the assets useful life. We are required to adopt the provisions of SFAS No. 143 effective December 29, 2002, the start of our fiscal year 2003. We do not believe SFAS No. 143 will impact us materially.

        In April 2002, the FASB issued SFAS No. 145 ("SFAS No. 145"), "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections". This statement updates, clarifies and simplifies existing accounting pronouncements and becomes effective for us starting in fiscal 2003. In most instances, SFAS No. 145 will require gains and losses on extinguishments of debt to be classified as income or loss from continuing operations rather than as extraordinary items as previously required under the old accounting rules. Starting in 2003, any gain or loss on extinguishment of debt previously classified, as an extraordinary item in prior periods presented that does not meet the criteria of APB 30 for such classification will be reclassified to conform to the provisions of SFAS No. 145. SFAS No. 145 will require us to reclassify our historical results, but will have no impact on our previously reported net earnings.

        In July 2002, the FASB issued Statement No. 146, Accounting for Costs Associated with Exit or Disposal Activities ("SFAS No. 146") and nullifies EITF Issue No. 94-3. FAS 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred, whereas EITF No 94-3 had recognized the liability at the commitment date to an exit plan. We are required to adopt the provisions of SFAS No. 146 effective for exit or disposal activities initiated after December 28, 2002. SFAS No. 146 had no impact on our financial statements, as presented, for fiscal year end 2002.

F-16


        In December 2002, the FASB issued SFAS No. 148 "Accounting for Stock-Based Compensation—Transition and Disclosure—an amendment of SFAS 123." Accounting for Stock-Based Compensation was issued to provide alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, this Statement amends the disclosure requirements of Statement No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. The amendments to Statement No. 123 in paragraphs 2(a)-2(e) of this Statement shall be effective for financial statements for fiscal years ending after December 15, 2002. Our plans are to continue to follow the intrinsic value approach of Accounting Principles Board Opinion No. 25 for determining compensation expense related to the issuance of stock options as permitted by SFAS No. 123 (see Notes 1 and 13 of Notes to Consolidated Financial Statements).

        In November 2002, the FASB issued Interpretation No. 45 "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others" which elaborates on the disclosures to be made by a guarantor in its interim and annual financial statements about its obligations under certain guarantees that it has issued. It also clarifies that a guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken in issuing the guarantee. This Interpretation does not prescribe a specific approach for subsequently measuring the guarantor's recognized liability over the term of the related guarantee. This Interpretation also incorporates, without change, the guidance in FASB Interpretation No. 34, "Disclosure of Indirect Guarantees of Indebtedness of Others", which is being superseded. The initial recognition and initial measurement provisions of this Interpretation are applicable on a prospective basis to guarantees issued or modified after December 31, 2002 and the disclosure requirements in this Interpretation are effective for financial statements of interim or annual periods ending after December 15, 2002. We do not believe, at December 28, 2002, we were a part to any indirect guarantees of indebtedness of others.

F-17



PLAYTEX PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands, except per share data)

 
  Twelve Months Ended
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

Net sales   $ 719,087   $ 723,518   $ 733,363
Cost of sales     328,433     333,807     334,983
   
 
 
  Gross profit     390,654     389,711     398,380
   
 
 
Operating expenses:                  
  Selling, general and administrative     240,620     233,660     228,093
  Restructuring and asset impairment     7,599        
  Amortization of intangibles     928     22,060     22,350
   
 
 
    Total operating expenses     249,147     255,720     250,443
   
 
 
      Operating earnings     141,507     133,991     147,937
Interest expense including related party interest expense of $12,150, net of related party interest income of $12,003 for all periods presented     59,543     75,861     84,884
Other expenses     2,653     2,103    
   
 
 
      Earnings before income taxes, extraordinary loss and cumulative effect of change in accounting principle     79,311     56,027     63,053
Income taxes     14,249     25,146     27,509
   
 
 
      Earnings before extraordinary loss and cumulative effect of change in accounting principle     65,062     30,881     35,544
   
 
 
Extraordinary loss on early extinguishment of debt, net of $2,147 tax benefit in 2002 and $12,829 tax benefit in 2001     (3,735 )   (19,336 )  
   
 
 
      Earnings before cumulative effect of change in accounting principle     61,327     11,545     35,544
   
 
 
Cumulative effect of change in accounting principle, net of $7,141 tax benefit     (12,423 )      
   
 
 
      Net earnings   $ 48,904   $ 11,545   $ 35,544
   
 
 
Earnings per share—Basic:                  
  Earnings before extraordinary loss and cumulative effect of change in accounting principle   $ 1.06   $ 0.51   $ 0.58
  Extraordinary loss     (0.06 )   (0.32 )  
  Cumulative effect of change in accounting principle     (0.20 )      
   
 
 
      Earnings per share—Basic   $ 0.80   $ 0.19   $ 0.58
   
 
 
Earnings per share—Diluted:                  
  Earnings before extraordinary loss and cumulative effect of change in accounting principle   $ 1.04   $ 0.51   $ 0.58
  Extraordinary loss     (0.06 )   (0.32 )  
  Cumulative effect of change in accounting principle     (0.19 )      
   
 
 
      Earnings per share—Diluted   $ 0.79   $ 0.19   $ 0.58
   
 
 
Weighted average common shares and equivalent common shares outstanding:                  
  Basic     61,148     61,007     60,824
  Diluted     63,948     61,115     62,585

See the accompanying notes to consolidated financial statements.

F-18



PLAYTEX PRODUCTS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 
  December 28,
2002

  December 29,
2001

 
Assets              
Current assets:              
  Cash   $ 31,605   $ 34,006  
  Receivables, less allowance for doubtful accounts     27,735     32,491  
  Retained interest in receivables     59,774     51,238  
  Inventories     85,160     82,193  
  Due from related party     80,017      
  Deferred income taxes, net     8,130     12,097  
  Other current assets     7,782     6,793  
   
 
 
    Total current assets     300,203     218,818  
Net property, plant and equipment     121,199     124,761  
Intangible assets, net:              
  Goodwill     494,307     494,187  
  Trademarks, patents and other     139,174     159,516  
Deferred financing costs     13,592     17,931  
Due from related party         80,017  
Other noncurrent assets     9,712     9,942  
   
 
 
    Total assets   $ 1,078,187   $ 1,105,172  
   
 
 
Liabilities and Stockholders' Equity              
Current liabilities:              
  Accounts payable   $ 47,088   $ 43,603  
  Accrued expenses     54,217     65,376  
  Due to related party     78,386      
  Income taxes payable     1,086     2,059  
  Current maturities of long-term debt     4,500      
   
 
 
    Total current liabilities     185,277     111,038  
Long-term debt     823,250     888,800  
Due to related party         78,386  
Other noncurrent liabilities     14,526     13,146  
Deferred income taxes, net     49,601     58,372  
   
 
 
    Total liabilities     1,072,654     1,149,742  
   
 
 
Stockholders' equity:              
  Common stock, $0.01 par value, authorized 100,000,000 shares, issued and outstanding 61,215,856 shares at December 28, 2002 and 61,044,199 shares at December 29, 2001     612     610  
  Additional paid-in capital     526,233     524,384  
  Retained earnings (deficit)     (516,771 )   (565,675 )
  Accumulated other comprehensive earnings     (4,541 )   (3,889 )
   
 
 
    Total stockholders' equity     5,533     (44,570 )
   
 
 
    Total liabilities and stockholders' equity   $ 1,078,187   $ 1,105,172  
   
 
 

See the accompanying notes to consolidated financial statements.

F-19



PLAYTEX PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
AND COMPREHENSIVE EARNINGS

(In thousands)

 
  Common
Shares
Outstanding

  Common
Stock

  Additional
Paid-In
Capital

  Retained
Earnings
(Deficit)

  Accumulated
Other
Comprehensive
Earnings

  Total
 
Balance, December 25, 1999   60,562   $ 605   $ 519,811   $ (612,764 ) $ (2,520 ) $ (94,868 )
Net earnings               35,544         35,544  
Foreign currency translation adjustment                   (638 )   (638 )
                               
 
  Comprehensive earnings                                 34,906  
Stock issued to employees exercising stock options   409     4     3,895             3,899  
   
 
 
 
 
 
 
  Balance, December 30, 2000   60,971     609     523,706     (577,220 )   (3,158 )   (56,063 )
Net earnings               11,545         11,545  
Foreign currency translation adjustment                   (731 )   (731 )
                               
 
  Comprehensive earnings                                 10,814  
Stock issued to employees exercising stock options   73     1     678             679  
   
 
 
 
 
 
 
  Balance, December 29, 2001   61,044     610     524,384     (565,675 ) $ (3,889 )   (44,570 )
Net earnings               48,904         48,904  
Foreign currency translation adjustment                   111     111  
Minimum pension liability adjustment                   (763 )   (763 )
                               
 
  Comprehensive earnings                                 48,252  
Stock issued to employees exercising stock options   172     2     1,849             1,851  
   
 
 
 
 
 
 
  Balance, December 28, 2002   61,216   $ 612   $ 526,233   $ (516,771 ) $ (4,541 ) $ 5,533  
   
 
 
 
 
 
 

See the accompanying notes to consolidated financial statements.

F-20



PLAYTEX PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 
  Twelve Months Ended
 
 
  December 28,
2002

  December 29, 2001
  December 30, 2000
 
Cash flows from operations:                    
  Net earnings   $ 48,904   $ 11,545   $ 35,544  
  Non-cash items included in earnings:                    
    Cumulative effect of change in accounting principle, net of tax benefit     12,423          
    Asset impairment charge     4,222          
    Extraordinary loss, net of tax benefits     3,735     19,336      
    Amortization of intangibles     928     22,060     22,350  
    Amortization of deferred financing costs     2,138     2,923     3,750  
    Depreciation     14,011     13,140     11,547  
    Deferred income taxes     2,342     12,902     11,383  
    Other, net     2,530     (1,016 )   (3,214 )
  Changes in working capital items, net of effects of business acquisitions:                    
    (Increase) decrease in receivables and retained interests     (3,780 )   47,241     (714 )
    (Increase) decrease in inventories     (2,967 )   3,133     170  
    (Increase) decrease in other current assets     (989 )   (1,377 )   223  
    Increase (decrease) in accounts payable     3,485     (7,932 )   6,428  
    Increase (decrease) in income taxes payable, net of impact of the extraordinary loss     1,174     10,292     (3,911 )
    (Decrease) in accrued expenses and other liabilities     (10,257 )   (5,312 )   (4,830 )
   
 
 
 
      Net cash flows from operations     77,899     126,935     78,726  
Cash flows used for investing activities:                    
  Purchases of property, plant and equipment     (16,445 )   (19,950 )   (22,724 )
  Intangible assets acquired     (975 )   (500 )   (279 )
   
 
 
 
      Net cash flows used for investing activities     (17,420 )   (20,450 )   (23,003 )
Cash flows (used for) provided by financing activities:                    
  Net (repayments) borrowings under revolving credit facilities     (17,000 )   17,000     (32,500 )
  Long-term debt borrowings     450,000     850,000      
  Long-term debt repayments     (494,050 )   (909,763 )   (23,813 )
  Payment of debt extinguishment fees and related expenses         (21,177 )    
  Payment of financing costs     (3,681 )   (19,500 )   (553 )
  Issuance of shares of common stock     1,851     679     3,899  
   
 
 
 
      Net cash flows used for financing activities     (62,880 )   (82,761 )   (52,967 )
(Decrease) increase in cash     (2,401 )   23,724     2,756  
Cash at beginning of period     34,006     10,282     7,526  
   
 
 
 
Cash at end of period   $ 31,605   $ 34,006   $ 10,282  
   
 
 
 
Supplemental disclosures of cash flow information Cash paid during the periods for:                    
    Interest   $ 55,939   $ 77,773   $ 80,979  
    Income taxes, net of refunds   $ 10,527   $ 1,926   $ 20,039  

See the accompanying notes to consolidated financial statements.

F-21



PLAYTEX PRODUCTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Summary of Significant Accounting Policies

        Principles of Consolidation—Our consolidated financial statements include the accounts of Playtex Products, Inc. and all of our subsidiaries ("Playtex Products, Inc."). All significant intercompany balances have been eliminated.

        Revenue Recognition—Revenues are recognized when we ship our products to customers and title transfers. In accordance with industry practice, we allow customers to return unused Sun Care products after the summer season. We record sales at the time the products are shipped and title transfers. Simultaneously, we reduce sales and cost of sales and reserve amounts on our balance sheet for anticipated returns based upon an estimated return level, in accordance with generally accepted accounting principles.

        Advertising and Sales Promotion Costs—Costs incurred for producing and communicating advertising, coupon and other consumer promotion activities and cooperative advertising programs with the trade are expensed when incurred.

        Shipping and Handling Costs—Freight costs are included in cost of goods sold in the Consolidated Statements of Earnings.

        Cash and cash equivalents—Cash equivalents are short-term, highly liquid instruments with original maturities of 90 days or less.

        Inventories—Inventories are stated at the lower of cost (first-in, first-out basis) or market. Inventory costs include material, labor and manufacturing overhead.

        Net Property, Plant and Equipment—Property, plant and equipment are stated at cost and depreciated on the straight-line method over the estimated useful life of the asset. Our estimated useful life for significant fixed asset classes is as follows:

  land improvements range from     machinery and equipment range from
        15 to 40 years,           4 to 20 years, and
  building and improvements range from     furniture and fixtures range from
        20 to 40 years,           5 to 10 years.

        Intangible Assets—Effective December 30, 2001, the beginning of our 2002 fiscal year, we adopted the provisions of Statement of Financial Accounting Standards ("SFAS") No. 141 "Business Combinations," and SFAS No. 142, "Goodwill and Other Intangible Assets." SFAS No. 141 requires business combinations initiated after June 30, 2001 to be accounted for using the purchase method of accounting. It also specifies the types of acquired intangible assets that are required to be recognized and reported separate from goodwill. SFAS No. 142 requires that goodwill and certain intangibles with indefinite lives no longer be amortized, but instead tested for impairment at least annually. We recorded a charge upon adoption of SFAS No. 142 of $12.4 million, net of $7.1 million in tax benefits, in the first quarter of 2002, reported as a cumulative effect of change in accounting principle (see Note 2).

        Long-Lived Assets—We review long-lived assets, including fixed assets and intangible assets with definitive lives, like patents, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We follow the guidance provided by SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

F-22


        Deferred Financing Costs—Expenses incurred to issue long-term debt have been capitalized and are being amortized on a straight line basis which approximates the effective yield method over the life of the related debt agreements and are included as a component of interest expense in the Consolidated Statements of Earnings. These deferred costs, net of accumulated amortization, amounted to $13.6 million and $17.9 million at December 28, 2002 and December 29, 2001, respectively.

        Income Taxes—Deferred tax assets and liabilities are provided using the asset and liability method for temporary differences between financial and tax reporting bases using the enacted tax rates in effect for the period in which the differences are expected to reverse. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that we expect to recover.

        Foreign Currency Translation—Assets and liabilities of our foreign subsidiaries have been translated into U.S. dollars at year-end exchange rates. Revenues and expenses have been translated at average exchange rates for the year. Net foreign translation gains or losses are accumulated in a separate section of stockholders' equity titled "Accumulated Other Comprehensive Earnings."

        Interest Rate Protection Agreements—We selectively enter into interest rate protection agreements to reduce our financial risk associated with changing interest rates. We have used two types of interest rate protection agreements in the past:

We do not utilize derivative financial instruments for trading or other speculative purposes. At December 28, 2002 and December 29, 2001, we were not a party to any debt interest rate protection agreements.

F-23


        Stock-Based Compensation—We account for stock-based compensation in accordance with SFAS No. 123, "Accounting for Stock-Based Compensation" (see Note 13). As permitted by SFAS No. 123, we follow the intrinsic value approach of Accounting Principles Board Opinion No. 25 for determining compensation expense related to the issuance of stock options. If we determined compensation expense under the alternate fair value approach permitted by SFAS No. 123, our earnings and earnings per share would have been reduced to the pro forma amounts listed below:

 
  Twelve Months Ended
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

 
  (In thousands, except per share data)

Net earnings:                  
  As reported   $ 48,904   $ 11,545   $ 35,544
  Pro forma   $ 45,132   $ 6,875   $ 32,024
Earnings per share:                  
  As reported                  
    Basic   $ 0.80   $ 0.19   $ 0.58
    Diluted   $ 0.79   $ 0.19   $ 0.58
  Pro forma                  
    Basic   $ 0.74   $ 0.11   $ 0.53
    Diluted   $ 0.73   $ 0.11   $ 0.53
Weighted average common shares and common equivalent shares outstanding:                  
  Basic     61,148     61,007     60,824
  Diluted     63,948     61,115     62,585

        The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

        Fiscal Year—Our fiscal year end is on the last Saturday in December nearest to December 31 and, as a result, a fifty-third week is added every 6 or 7 years. Fiscal 2002 and fiscal 2001 were fifty-two week years and fiscal 2000 was a fifty-three week year.

        Use of Estimates—The preparation of financial statements in accordance with generally accepted accounting principles requires us to make estimates and assumptions. These estimates and assumptions affect:

F-24


Actual results could vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make as well as assumptions by third parties. The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware (see Management's Discussion and Analysis-Critical Accounting Policies). As part of our customary review and reconciliation process, we periodically record adjustments to our accounting estimates. During the second quarter ended June 29, 2002, we recorded additional expenses of $2.0 million to cover higher than expected Sun Care returns from the 2001 Sun Care season. Also, we reduced our reserves for certain advertising and sales promotion programs conducted prior to 2002 by $1.7 million based on the actual costs of these programs versus our original estimates.

        Reclassifications—For comparative purposes, we reclassified certain previously reported selling, general, and administrative expenses to an offset to net sales (see Note 2). In addition, we reclassified certain expenses from the cost of sales line item to the selling, general and administrative line item to better reflect the nature of these expenses. These reclassifications were made to conform to our current year presentation.

2. Impact of New Accounting Pronouncements

        In May 2000, the Emerging Issues Task Force ("EITF") of the Financial Accounting Standards Board ("FASB") reached a consensus on Issue No. 00-14, "Accounting for Certain Sales Incentives." In April 2001, the EITF of the FASB reached a consensus on Issue No. 00-25, "Vendor Income Statement Characterization of Consideration from a Vendor to a Reseller." In November of 2001, both of these EITFs were codified in with related issues into EITF No. 01-9, "Accounting for Consideration Given By a Vendor To a Customer (Including a Reseller of the Vendor's Products)." We adopted the requirements of these Issues effective December 30, 2001, the start of our fiscal year 2002. These issues address the recognition, measurement, and income statement classification for certain advertising, promotional and cooperative spending activities. As a result of the adoption of these issues, we reclassified certain previously reported selling, general and administrative expenses to offset net sales to conform to our current year presentation. These reclassifications reduced both our net sales and selling, general and administrative expenses by equal and offsetting amounts and had no impact on our reported operating earnings, net income, or earnings per share.

        Effective December 30, 2001, the beginning of our 2002 fiscal year, we adopted the provisions of SFAS No. 142, which changed our accounting for goodwill and other intangible assets with indefinite lives from an amortization method to an impairment only approach. As such, we stopped the amortization of goodwill and other intangible assets with indefinite lives on December 29, 2001. The standard requires a reassessment of the useful lives of identifiable intangible assets, other than goodwill, and at minimum an annual test for impairment of goodwill and intangibles with indefinite lives.

        In accordance with the requirements of SFAS No. 142, we tested the goodwill attributable to each of our reporting units for impairment as of December 30, 2001, the first day of fiscal 2002, and determined that none of our goodwill was impaired. We are required to test our goodwill for impairment, based on the methodologies as outlined in SFAS No. 142, on an annual basis and more frequently if events or circumstances indicate a likelihood of impairment. We performed an additional test, as part of the required annual goodwill impairment testing, at the end of the first quarter of 2002. The results of this test, like the test performed at December 29, 2001, confirmed that none of our goodwill was impaired.

F-25


        In addition, we reassessed the useful lives of our identifiable intangible assets and determined that our trademarks have indefinite lives. As required by SFAS No. 142, we stopped the amortization of our trademarks on December 29, 2001. We will continue to amortize our patents, which are identifiable intangible assets with definite useful lives. Also, in accordance with the requirements of SFAS No. 142, we tested each of our trademarks for impairment by comparing the fair value of each trademark to its carrying value at December 30, 2001. Fair value was estimated using the relief from royalty method (a discounted cash flow methodology). Based on these impairment tests, we recorded a charge, reported as a cumulative effect of change in accounting principle, of $19.6 million ($12.4 million or $0.19 per diluted share, net of tax benefits) in the first quarter of 2002. This charge reduced the trademark carrying value of certain non-core brands, primarily Chubs and Diaparene, to their estimated fair value. We will test the carrying value of trademarks for impairment at least annually and more frequently if events or circumstances indicate a likelihood of impairment. Patents will continue to be tested for impairment under SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets."

        Had we accounted for goodwill and other intangible assets under the non-amortization provisions of SFAS No. 142 for fiscal 2001 and fiscal 2000, our net earnings and earnings per share would have been as follows (in thousands except per share amounts):

 
  Twelve Months Ended
 
  December 29,
2001

  December 30,
2000

Net earnings:            
  Reported net earnings   $ 11,545   $ 35,544
  Add back goodwill and trademark amortization expense, net of tax     18,084     18,084
   
 
    Adjusted net earnings   $ 29,629   $ 53,628
   
 
Earnings per share—Basic and Diluted:            
  Reported earnings per share   $ 0.19   $ 0.58
  Impact of goodwill and trademark amortization expense, net of tax     0.29     0.29
   
 
    Adjusted earnings per share   $ 0.48   $ 0.87
   
 

        Effective December 30, 2001, we adopted SFAS 144 "Accounting for the Impairment or Disposal of Long-Lived Assets" ("SFAS 144"). SFAS 144 retains the fundamental provisions of SFAS 121 "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of" while also resolving significant implementation issues associated with SFAS 121. The adoption of this statement did not have a material impact on our consolidated financial statements.

        In April 2002, the Financial Accounting Standards Board (FASB) issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections" (SFAS 145). SFAS 145 requires that certain gains and losses on extinguishments of debt be classified as income or loss from continuing operations rather than as extraordinary items as previously required under SFAS 4, "Reporting Gains and Losses from Extinguishment of Debt". This statement also amends SFAS No. 13, "Accounting for Leases", to require certain modifications to capital leases be treated as a sale-leaseback and modifies the accounting for sub-leases when the original lessee remains a secondary obligor (or guarantor). We will be required to adopt SFAS 145 on December 29, 2002, the first day of fiscal 2003. Upon adoption, we will be required to reclassify the $3.7 million and the $19.3 million of extraordinary losses, net of tax recorded in 2002 and 2001, resulting from their amended Credit Facility and refinancing of their senior indebtedness to continuing operations, respectively.

F-26


        In June 2002, the FASB issued SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities" (SFAS 146). SFAS 146 will spread out the reporting of expenses related to restructurings initiated after 2002, because commitment to a plan to exit an activity or dispose of long-lived assets will no longer be enough to record a liability for the anticipated costs. Instead, companies will record exit and disposal costs when they are "incurred" and can be measured at fair value, and they will subsequently adjust the recorded liability for changes in estimated cash flows. The provisions of SFAS 146 are effective for exit and disposal activities that are initiated after December 31, 2002. We will continue to apply the provisions of EITF Issue 94-3 to any exit activities that have been initiated under an exit plan that met the criteria of EITF Issue 94-3 before the adoption of SFAS 146.

3. Restructuring and Impairment Costs

        In 2002, we recorded a pre-tax restructuring and asset impairment charge of $7.6 million, or $0.08 per diluted share, as a result of our decision to close our Watervliet, New York plastic molding facility. The write-off of assets associated with the closure of the facility was approximately $4.2 million and severance and other exit costs related to the termination of employees was estimated at $3.4 million. We spent $1.6 million related to severance and other exit costs during 2002. The Watervliet facility manufactured component parts primarily for our infant feeding category and employed approximately 160 people at the time of the announcement.

4. Accumulated Other Comprehensive Earnings

        In 2002, we recorded a minimum pension liability adjustment related to the under funded status of our Canadian pension plan (see Note 16). The accumulated balances for each classification of comprehensive earnings are as follows (in thousands):

 
  Foreign
Currency
Translation
Adjustment

  Minimum
Pension
Liability
Adjustment

  Accumulated
Other
Comprehensive
Earnings

 
Balance, December 25, 1999   $ (2,520 ) $   $ (2,520 )
  Change in period     (638 )       (638 )
   
 
 
 
Balance, December 30, 2000     (3,158 )       (3,158 )
  Change in period     (731 )       (731 )
   
 
 
 
Balance, December 29, 2001     (3,889 )       (3,889 )
  Change in period     111     (763 )   (652 )
   
 
 
 
Balance, December 28, 2002   $ (3,778 ) $ (763 ) $ (4,541 )
   
 
 
 

F-27


5. Business Segments and Geographic Area Information

Business Segments

        We are organized in three divisions, which are categorized as business segments in accordance with generally accepted accounting principles.

        Our Personal Products Division includes Infant Care and Feminine Care products sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Infant Care product category includes the following brands:

  Playtex disposable nurser system,     Baby Magic infant toiletries
        cups and reusable hard bottles     Mr. Bubble children's bubble bath
  Wet Ones pre-moistened towelettes     Baby Magic baby wipes, and
  Diaper Genie diaper disposal system     Binky pacifiers.

The Feminine Care product category includes a wide range of plastic and cardboard applicator tampons. As well as complementary products, marketed under such brand names as:

Tampons   Complementary Products
  Playtex Gentle Glide,     Playtex Personal Cleansing Cloths
  Playtex Portables,           for use in feminine hygiene, and
  Playtex Slimfits,     Playtex Heat Therapy patch to
  Playtex Silk Glide,           alleviate discomfort associated
    with menstrual pain.

        Our Consumer Products Division includes a number of leading and well-recognized brands sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Consumer Products Division includes the following brands:

  Banana Boat Sun Care products     Binaca breath spray and drops
  Woolite rug and upholstery cleaning products     Tussy deodorant
  Playtex Gloves     Dentax oral care products, and
  Ogilvie at-home permanents     Tek toothbrushes

        Our International/Corporate Sales Division includes:

  Sales to specialty classes of trade in
    the United States including: warehouse
    clubs, military, convenience stores,
    specialty stores, and telemarketing
 



  export sales
sales in Puerto Rico
results from our Canadian and Australian
    subsidiaries
sales of private label tampons

        The International/Corporate Sales Division sells the same products as are available to our U.S. customers.

F-28


        We evaluate division performance based on their product contribution excluding general corporate allocations. In 2002, we reclassified certain unallocated charges from the cost of sales line item to the selling, general and administrative line item to better reflect the nature of these expenses. Product contribution is defined as gross profit less advertising and sales promotion expenses. All other operating expenses are managed at a corporate level and are not used by us to evaluate division results. We do not segregate assets, amortization, capital expenditures, or interest income and interest expense to divisions (in thousands).

 
  Twelve Months Ended
 
 
  December 28, 2002
  December 29, 2001
  December 30, 2000
 
 
  Net
Sales

  Product
Contribution

  Net
Sales

  Product Contribution
  Net
Sales

  Product
Contribution

 
Personal Products   $ 422,184   $ 196,850   $ 421,831   $ 192,301   $ 433,259   $ 192,837  
Consumer Products     159,820     49,152     171,917     57,047     174,417     61,244  
International/Corporate Sales     137,083     61,974     129,770     58,457     125,687     56,825  
Unallocated charges         (642 )       (926 )       (1,142 )
   
 
 
 
 
 
 
  Total consolidated   $ 719,087     307,334   $ 723,518     306,879   $ 733,363     309,764  
   
       
       
       
Reconciliation to operating earnings:                                      
Selling, distribution, research and administrative           157,300           150,828           139,477  
Restructuring and asset impairment           7,599                      
Amortization of intangibles           928           22,060           22,350  
         
       
       
 
  Operating earnings         $ 141,507         $ 133,991         $ 147,937  
         
       
       
 

        The amount of depreciation allocated to the divisions is as follows (in thousands):

 
  Twelve Months Ended
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

Personal Products   $ 7,655   $ 7,165   $ 6,332
Consumer Products     1,642     1,601     1,369
International/Corporate Sales     974     1,006     834
   
 
 
  Depreciation included in product contribution     10,271     9,772     8,535
Depreciation not allocated to divisions     3,740     3,368     3,012
   
 
 
  Consolidated depreciation   $ 14,011   $ 13,140   $ 11,547
   
 
 

F-29


Geographic Area Information

        Net sales and product contribution represents sales to unaffiliated customers only. Intergeographic sales and transfers between geographic areas are minimal and are not disclosed separately. Net sales and product contribution within the United States includes all 50 states and its territories. Corporate charges that are not allocated to divisions (see preceding table) are included in product contribution for the United States. International net sales and product contribution represents business activity outside of the United States and its territories (in thousands).

 
  Twelve Months Ended
 
  December 28, 2002
  December 29, 2001
  December 30, 2000
 
  Net
Sales

  Product
Contribution

  Net
Sales

  Product
Contribution

  Net
Sales

  Product
Contribution

United States   $ 663,659   $ 287,238   $ 667,830   $ 287,272   $ 676,014   $ 288,320
International     55,428     20,096     55,688     19,607     57,349     21,444
   
 
 
 
 
 
  Total   $ 719,087   $ 307,334   $ 723,518   $ 306,879   $ 733,363   $ 309,764
   
 
 
 
 
 

        Identifiable assets by geographic area represent those assets that are used in our operations in each area.

Identifiable Assets

  December 28,
2002

  December 29,
2001

United States   $ 1,053,007   $ 1,085,029
International     25,180     20,143
   
 
  Total   $ 1,078,187   $ 1,105,172
   
 

6. Balance Sheet Components

        The components of certain balance sheet accounts are as follows (in thousands):

 
  December 28,
2002

  December 29,
2001

 
Cash   $ 23,105   $ 27,103  
Cash—lock box(1)     8,500     6,903  
   
 
 
  Net   $ 31,605   $ 34,006  
   
 
 
Receivables   $ 28,707   $ 33,767  
Less allowance for doubtful accounts     (972 )   (1,276 )
   
 
 
  Net   $ 27,735   $ 32,491  
   
 
 
Inventories:              
  Raw materials   $ 18,780   $ 23,715  
  Work in process     2,125     1,934  
  Finished goods     64,255     56,544  
   
 
 
    Total   $ 85,160   $ 82,193  
   
 
 

(1)
Cash held in lock box pending weekly settlement procedure for Receivables Facility (see Note 9).

F-30


 
  December 28,
2002

  December 29,
2001

 
Net property, plant and equipment:              
  Land   $ 2,376   $ 2,376  
  Buildings     39,694     41,047  
  Machinery and equipment     183,200     186,557  
   
 
 
      225,270     229,980  
  Less accumulated depreciation     (104,071 )   (105,219 )
   
 
 
    Net   $ 121,199   $ 124,761  
   
 
 
Goodwill   $ 667,151   $ 667,031  
Less accumulated amortization     (172,844 )   (172,844 )
   
 
 
    Net   $ 494,307   $ 494,187  
   
 
 
Trademarks, patents, and other   $ 163,300   $ 182,714  
Less accumulated amortization     (24,126 )   (23,198 )
   
 
 
    Net   $ 139,174   $ 159,516  
   
 
 
Deferred financing costs   $ 16,306   $ 19,500  
Less accumulated amortization     (2,714 )   (1,569 )
   
 
 
    Net   $ 13,592   $ 17,931  
   
 
 
Accrued expenses:              
  Advertising and sales promotion   $ 16,665   $ 20,687  
  Employee compensation and benefits     15,769     14,743  
  Interest     7,864     6,398  
  Insurance     1,501     3,238  
  Other     12,418     20,310  
   
 
 
    Total   $ 54,217   $ 65,376  
   
 
 

7. Due from Related Party

        Our business is unrelated to the business of Playtex Apparel, Inc. ("Apparel"), which was spun-off from us in 1988 in a reorganization of the Company. Two of our former directors and senior executive officers are general partners of the investor group (the "Apparel Partnership"), which controlled Apparel until it was later sold. Playtex Investment Corp., one of our wholly-owned subsidiaries, is the holder of 15% debentures issued by the Apparel Partnership due December 15, 2003. Interest on the debentures is payable annually in cash or additional debentures. The Apparel Partnership decided to make its debenture payments in additional debentures through their December 15, 1993 payment and have paid in cash since then. The obligations of the Apparel Partnership are nonrecourse to the partners of the Apparel Partnership. The unaudited assets of the Apparel Partnership are Sara Lee Corporation common stock with a market value of approximately $5.9 million at December 28, 2002 and December 29, 2001. Cash of approximately $1.4 million at December 28, 2002 and $1.1 million at December 29, 2001 and our 151/2% subordinated notes held by them (see Note 11). We believe its debentures, which we hold, represent its only material liability.

F-31


8. Long-Term Debt

        Long-term debt, excluding amounts due to related party, consists of the following (in thousands):

 
  December 28,
2002

  December 29,
2001

Variable rate indebtedness:            
  Term A Loan   $   $ 76,000
  Term B Loan         395,800
  Term C Loan     447,750    
  Revolving Credit Facility         17,000
Fixed rate indebtedness:            
  93/8% Senior Subordinated Notes due 2011     350,000     350,000
  6% Convertible Subordinated Notes due 2004     30,000     50,000
   
 
      827,750     888,800
  Less current maturities     (4,500 )  
   
 
    Total long-term debt   $ 823,250   $ 888,800
   
 

        One of our major corporate objectives has been to reduce our outstanding indebtedness and lower our borrowing costs. We reduced our indebtedness by: $61.1 million in fiscal 2002; $42.8 million in fiscal 2001; and $56.3 million in fiscal 2000. Highlights of this strategy include:

F-32


Fixed Rate Indebtedness

        Our fixed rate indebtedness at December 28, 2002 of $380.0 million consists of our 93/8% Notes and the Convertible Notes. We pay interest on the 93/8% Notes semi-annually on June 1 and December 1 of each year. At any time prior to June 1, 2004, we may redeem up to 35% of the principal amount of the 93/8% Notes with the proceeds of one or more equity offerings at a redemption price of 109.375% of the principal amount, plus accrued and unpaid interest to the redemption date. We do not have the option to redeem the 93/8% Notes from June 1, 2004 through May 31, 2006. At our option, we may redeem the notes on or after June 1, 2006 at the redemption prices (expressed as a percentage of principal amount) listed below plus accrued and unpaid interest to the redemption date.

Year

  Percentage
2006   104.688
2007   103.125
2008   101.563
2009 and thereafter   100.000

        The Convertible Notes are currently redeemable by us, in whole or in part, at our option at a redemption price equal to 100% of the principal amount, together with accrued and unpaid interest to the redemption date. On November 6, 2002, we redeemed $20.0 million principal amount of our Convertible Notes as discussed previously. The Convertible Notes are convertible into approximately 1.6 million shares of our common stock at a conversion price of approximately $19.15 per common share. The Convertible Notes mature on January 31, 2004.

Variable Rate Indebtedness

        Our variable rate indebtedness of $447.7 million at December 28, 2002, consists solely of the $447.7 million outstanding under the Term C Loan. We did not have any borrowings outstanding against our Revolving Credit Facility at December 28, 2002. The rates of interest we pay under the Term C Loan and Revolving Credit Facility vary over time depending on short-term interest rates. We also pay fees on our Revolving Credit Facility commitments, which vary depending on our credit rating. Loans made under the Revolving Credit Facility mature on May 22, 2007 and our final principal payment on the Term C Loan is due May 31, 2009. Scheduled principal payments on the Term C Loan are made semi-annually and amount to: approximately $4.5 million per year in fiscal years 2003 through 2007, approximately $213.7 million in 2008, and $211.5 million in 2009. We paid one $2.3 million semi-annual payment on the Term C Loan during fiscal 2002. At December 28, 2002, we had $121.6 million of unused borrowings available to us under the Revolving Credit Facility, net of outstanding letters of credit.

        We periodically use financial instruments, such as derivatives, to manage the impact of interest rate changes on our variable rate debt. At December 28, 2002 and December 29, 2001, we were not a party to any derivative or other type of financial instrument that hedged the impact of interest rate changes on our variable rate debt. Based on our interest rate exposure at December 28, 2002, a 1% increase in interest rates would result in an estimated $4.5 million of additional interest expense on an annualized basis.

F-33


        The rates of interest we pay on our variable rate debt are, at our option, a function of various alternative short term borrowing rates, like the Prime Rate or LIBOR.

        The provisions of the credit agreement for our Credit Facility require us to meet certain financial covenants and ratios and include limitations and restrictions, including:

  indebtedness and liens,     certain dividends and other distributions,
  major acquisitions or mergers,     the application of excess cash flow, and
  capital expenditures and asset sales,     prepayment and modification of all
    indebtedness or equity capitalization.

        The 93/8% Notes also contain certain restrictions and requirements. Under the terms of each of these agreements, payment of cash dividends on our common stock is restricted. Certain of our wholly owned subsidiaries are guarantors of the 93/8% Notes (see Note 20).

        Our required principal repayments are (excluding amounts due to related party):

  $4.5 million in 2003,     $4.5 million in 2006,
  $34.5 million in 2004,     $4.5 million in 2007, and
  $4.5 million in 2005,     $775.2 million thereafter.

        In the event that we have excess cash flow, as defined in our Credit Facility, we may, within 90 days of each year-end, be required to: make either mandatory debt repayments on the Term C Loan equal to the amount of the excess cash flow, as defined, or make deposits into the excess cash flow account equal to the amount of the excess cash flow. In March of 2003, we deposited $19.1 million into the excess cash flow account and we intend to use these funds to repay a portion of our 6% Convertible Notes in April of 2003.

9. Receivables Facility

        On May 22, 2001, we entered into the Receivables Facility through a wholly-owned, consolidated special purpose bankruptcy remote subsidiary of ours, Playtex A/R LLC. Through the Receivables Facility, we sell on a continuous basis to Playtex A/R LLC substantially all of our domestic customers' trade invoices that we generate. Playtex A/R LLC sells to a third-party commercial paper conduit (the "Conduit") an undivided fractional ownership interest in these trade accounts receivable. The Conduit issues short-term commercial paper to finance the purchase of the undivided fractional interest in the receivables. The total funding available to us on a revolving basis under the Receivables Facility is up to $100.0 million, depending primarily on: the amount of receivables generated by us and sold to Playtex A/R LLC, the rate of collection on those receivables, and other characteristics of the receivables pool which affects their eligibility. Proceeds from the draw down on the Receivables Facility of amounts greater than $75.0 million must be used to repay the Term C Loan, the first time such amounts are utilized. Our Retained Interest in Receivables represents our subordinated fractional undivided interest in receivables sold to Playtex A/R LLC and the net unamortized deferred financing costs incurred by Playtex A/R LLC.

F-34


        We have agreed to continue servicing the sold receivables at market rates; accordingly, no servicing asset or liability has been recorded. Playtex A/R LLC shares credit risk with the Conduit as the undivided fractional interest in the receivables are sold without recourse. We believe, however, that Playtex A/R LLC has most of the credit risk associated with customers that do not pay, as the Conduit has preferential treatment with regard to cash settlement procedures and other conditions that limit their credit exposure. Our retained interest in receivables will be negatively impacted if Playtex A/R LLC writes-off any receivable balances as uncollectible. We believe the Receivables Facility is beneficial to us as: (1) we convert trade receivables to cash faster, and (2) although we sell our invoices to Playtex A/R LLC at a discount and pay fees to the Conduit, these expenses are lower than our borrowing costs under the Credit Facility.

        At December 28, 2002, Playtex A/R LLC had $98.3 million of receivables, of which $39.0 million of undivided fractional interest therein was sold to the Conduit. Since the beginning of fiscal 2002, we have sold in aggregate approximately $628.0 million of accounts receivable to Playtex A/R LLC. In return, we have received from Playtex A/R LLC approximately $624.5 million of cash.

        We sell receivables at a discount, which is included in Other Expenses in the Consolidated Statements of Earnings. This discount, which was $2.7 million in 2002 and $2.1 million in 2001, reflects the estimated fees required by the Conduit to purchase a fractional undivided interest in the receivables. The fees are based on the payment characteristics of the receivables, most notably their average life, interest rates in the commercial paper market and historical credit losses. Also included in Other Expenses is the impact of the amortization of deferred financing costs incurred by Playtex A/R LLC to establish the Receivables Facility.

        We account for the sale of accounts receivable to Playtex A/R LLC and related transactions with the Conduit in accordance with SFAS No. 140, "Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities." At the time the receivables are sold, the balances are removed from our balance sheet. Playtex A/R LLC pays fees on the value of the undivided interest of the receivables sold to the conduit equal to the 30 day LIBOR rate, which is reset weekly. In addition, Playtex A/R LLC pays a 0.25% per annum fee on the utilized portion of the Receivables Facility and a 0.45% per annum liquidity fee on the entire committed amount of the Receivables Facility. Because of the short-term nature, generally less than 60 days, of our trade accounts receivable sold to Playtex A/R LLC and the historically low credit risk associated with these receivables, the carrying value of our Retained Interest in Receivables approximates the fair value.

        Commitments under the Receivables Facility have terms of 364 days, which may be renewed annually at the option of the Conduit. In May 2002, the Receivables Facility was extended through May 2003. The Receivables Facility may be terminated prior to its term in the event of:

  nonpayment of fees or     bankruptcy events,
        other amounts when due,     material judgments,
  violation of covenants,     defaults under the Receivables Facility,
  failure of any representation or warranty to     a servicing default, and
        be true in all material respects     a downgrade in the Senior Secured Credit
        when made,           Facility to less than B- by S&P
    and less than B3 by Moody's.

F-35


10. Extraordinary Loss

        We recorded an extraordinary loss of $3.7 million, net of $2.2 million in tax benefits, or $0.06 per diluted share during fiscal 2002 as a result of the amendment to our Credit Facility. On May 29, 2002, we amended our Credit Facility and issued a new $450.0 million Term C Loan and, together with $21.8 million of cash, we repaid in full our outstanding obligations under our Term A Loan and Term B Loan, which collectively totaled $471.8 million (see Note 8). The extraordinary loss was associated with the write-off of unamortized deferred financing costs relating to our Term A Loan and Term B Loan.

        In 2001, we recorded an extraordinary loss of $19.3 million, net of income tax benefits of $12.8 million, or $0.32 per diluted share as a result of the Refinancing Transaction (see Note 8). This extraordinary loss included call premiums on our retired fixed rate indebtedness, the write-off of unamortized deferred financing costs, fees for two interest rate swap agreements related to our prior credit facility and duplicative net interest expense during the period between extinguishment and redemption of the fixed rate indebtedness.

11. Due to Related Party

        Due to related party consists of 151/2% subordinated notes issued by us and held by the Apparel Partnership. The subordinated notes are due on December 15, 2003 and interest on them is payable annually in cash or additional 151/2% subordinated notes. We decided to make our interest payments on the subordinated notes in additional subordinated notes through our December 15, 1993 payment and have paid in cash since then (see Note 7).

12. Income Taxes

        The provision for income taxes is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Deferred income tax assets and liabilities are calculated for differences between the financial statement and tax bases of assets and liabilities. These differences will result in taxable or deductible amounts in the future. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts we expect to realize.

        Earnings before income taxes, extraordinary loss and cumulative effect of change in accounting principle are as follows (in thousands):

 
  Twelve Months Ended
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

U.S.   $ 76,979   $ 53,719   $ 59,519
Foreign     2,332     2,308     3,534
   
 
 
  Total   $ 79,311   $ 56,027   $ 63,053
   
 
 

F-36


        Our provisions for income taxes are as follows (in thousands):

 
  Twelve Months Ended
 
  December 28,
2002

  December 30,
2001

  December 30,
2000

Current:                  
  Federal   $ 13,126   $ 11,281   $ 13,580
  State and local     756     40     982
  Foreign     (1,975 )   923     1,564
   
 
 
      11,907     12,244     16,126
Deferred:                  
  Federal     1,412     11,871     10,292
  State and local     631     1,003     1,091
  Foreign     299     28    
   
 
 
      2,342     12,902     11,383
   
 
 
    Total   $ 14,249   $ 25,146   $ 27,509
   
 
 

        In 2002, we recorded an extraordinary loss of $3.7 million, net of $2.2 million of tax benefits, associated with the write-off of the unamortized deferred financing costs relating to our Term A Loan and Term B Loan (see Notes 8 and 10). In addition, during 2002, the U.S. Treasury issued new regulations that replace the loss disallowance rules applicable to the sale of stock of a subsidiary member of a consolidated tax group. These regulations permit us to utilize a previously disallowed $135.1 million tax capital loss that resulted from the sale of Playtex Beauty Care Inc. during fiscal 1999. We can utilize the tax capital loss associated with the sale of Playtex Beauty Care Inc. to offset capital gains during the statutory five-year carry forward period. We anticipate utilizing $40.0 million of the capital loss to offset a capital gain, in fiscal 2003, related to the deferred capital gain associated with the 1988 spin-off of the Apparel business. The tax gain created by the spin-off of the Apparel business will come due on December 15, 2003 in conjunction with the retirement of the Related Party Notes (see Notes 7 and 11). Accordingly, we recorded a tax benefit of $14.3 million, or $0.22 per diluted share, in fiscal 2002. The remaining capital loss carryover will expire on December 25, 2004, if not utilized. The remaining tax benefit associated with the capital loss carryforward has been reduced by a valuation allowance, as we do not currently expect to realize it.

        In 2001, we recorded an extraordinary loss of $19.3 million, net of $12.8 million of tax benefits, as a result of the Refinancing Transaction (see Notes 8 and 10). This extraordinary loss included call premiums on our retired fixed rate indebtedness, the write-off of unamortized deferred financing costs, fees for two interest rate swap agreements related to our prior credit facility and duplicative net interest expense during the period between extinguishment and redemption of the fixed rate indebtedness.

F-37


        Taxable and deductible temporary differences and tax credit carryforwards which give rise to our deferred tax assets and liabilities at December 28, 2002 and December 29, 2001 are as follows (in thousands):

 
  December 28,
2002

  December 29,
2001

Deferred tax assets:            
  Capital loss carryover   $ 49,020   $
  Allowances and reserves not currently deductible     8,135     12,069
  Postretirement benefits reserve     5,479     4,790
  Net operating loss carryforwards     1,521     2,462
  Other     1,265     1,376
   
 
    Subtotal     65,420     20,697
  Less: valuation allowance     (34,722 )  
   
 
    Total   $ 30,698   $ 20,697
   
 
Deferred tax liabilities:            
  Property, plant and equipment   $ 27,830   $ 25,125
  Trademarks     23,600     23,056
  Deferred gain on sale of business     14,298     14,298
  Undistributed earnings of foreign subsidiary     4,490     2,515
  Other     1,951     1,978
   
 
    Total   $ 72,169   $ 66,972
   
 

        We have available net operating loss carryforwards ("NOLs") of $4.3 million at December 28, 2002 that expire in years 2009 through 2012. These NOLs relate primarily to operations of Banana Boat Holdings and Carewell prior to our acquisition of them. We can utilize these NOLs, with certain limitations, on our federal, state and local tax returns. We expect to utilize these NOLs prior to their expiration. The current benefit realized from these NOLs was $1.0 million for each of the last three fiscal years.

        Our tax provision before extraordinary loss and cumulative effect of change in accounting principle differed from the amount computed using the federal statutory rate of 35% as follows (in thousands):

 
  Twelve Months Ended
 
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

 
Expected federal income tax at statutory rates   $ 27,759   $ 19,609   $ 22,069  
Deferred tax expense for undistributed foreign earnings     1,975          
State and local income taxes     902     678     1,347  
Amortization of intangible assets         4,496     4,496  
Benefit of capital loss carryover     (14,298 )        
Benefit of favorable foreign tax audit     (2,275 )        
Other, net     186     363     (403 )
   
 
 
 
  Total tax provision   $ 14,249   $ 25,146   $ 27,509  
   
 
 
 

F-38


13. Stock-Based Compensation

        We established a long-term incentive plan under which awards of stock options are granted. Options granted under the plan must:

        Except for formula grants to certain non-employee directors, which vest over a five-year period, options vest over a period determined by the Compensation and Stock Option Committee. We have 1,122,285 shares available to grant as options and 7,968,966 shares authorized but unissued under the plan at December 28, 2002.

        The following table summarizes our stock option activity over the past three fiscal years:

 
  2002
  2001
  2000
 
  Shares
  Weighted
Average
Exercise
Price

  Shares
  Weighted
Average
Exercise
Price

  Shares
  Weighted
Average
Exercise
Price

Outstanding at beginning of year   6,356,330   $ 11.17   5,191,129   $ 11.59   4,581,326   $ 11.86
Granted   840,000     12.38   1,517,000     9.90   1,732,500     10.85
Exercised   (171,657 )   9.57   (73,300 )   8.73   (436,572 )   8.79
Forfeited   (177,992 )   12.16   (278,499 )   12.59   (686,125 )   13.35
   
       
       
     
Outstanding at end of year   6,846,681     11.34   6,356,330     11.17   5,191,129     11.59
   
       
       
     
Options exercisable at year-end   4,602,593     11.51   3,689,976     11.57   2,832,780     11.12
Weighted-average fair value of options granted during the year       $ 6.08       $ 4.75       $ 5.43

        The following table summarizes information about our stock options outstanding at December 28, 2002:

 
  Options Outstanding
  Options Exercisable
Range of Exercise Prices

  Shares
  Weighted
Average
Remaining
Contractual
Life

  Weighted
Average
Exercise
Prices

  Shares
  Weighted
Average
Exercise
Prices

$7.00 to 8.00   338,261   2.66   $ 7.8750   338,261   $ 7.8750
$8.00 to 9.00   153,500   3.45     8.6714   153,500     8.6714
$9.00 to 10.00   1,845,597   4.99     9.7057   1,388,042     9.7552
$10.00 to 11.00   2,068,323   7.71     10.5118   1,126,121     10.5897
$11.00 to 13.00   977,000   8.43     12.4369   150,668     12.7642
$13.00 to 14.00   141,000   5.99     13.8564   123,001     13.8902
$14.00 to 15.00   832,000   5.74     14.7251   832,000     14.7251
$15.00 to 16.00   491,000   6.38     15.5000   491,000     15.5000
   
           
     
$7.00 to 16.00   6,846,681   6.36     11.3363   4,602,593     11.5053
   
           
     

F-39


14. Earnings Per Share

        The following table explains how our basic and diluted Earnings Per Share ("EPS") were calculated for the last three fiscal years (in thousands, except per share data):

 
  Twelve Months Ended
 
  December 28,
2002

  December 29,
2001

  December 30,
2000

Numerator:                  
Earnings before extraordinary loss and cumulative effect of change in accounting principle—as reported   $ 65,062   $ 30,881   $ 35,544
Effect of Dilutive Securities:                  
Adjustment for interest on Convertible Notes, net of tax     1,780         946
   
 
 
Earnings before extraordinary loss and cumulative effect of change in accounting principle adjusted for assumed dilutive conversion     66,842     30,881     36,490
Extraordinary loss, net of tax benefits     (3,735 )   (19,336 )  
Cumulative effect of change in accounting principle, net of tax benefits     (12,423 )      
   
 
 
  Net earnings—Diluted   $ 50,684   $ 11,545   $ 36,490
   
 
 
Denominator:                  
Weighted average common shares outstanding—Basic     61,148     61,007     60,824
Effect of Dilutive Securities:                  
Adjustment for dilutive effect of stock options     341     108     456
Adjustment for dilutive effect of Convertible Notes     2,459         1,305
   
 
 
  Weighted average common shares outstanding—Diluted     63,948     61,115     62,585
   
 
 
Earnings per share—Basic:                  
Earnings before extraordinary loss and cumulative effect of change in accounting principle   $ 1.06   $ 0.51   $ 0.58
Extraordinary loss, net of tax benefits     (0.06 )   (0.32 )  
Cumulative effect of change in accounting principle, net of tax benefits     (0.20 )      
   
 
 
  Net earnings   $ 0.80   $ 0.19   $ 0.58
   
 
 
Earnings per share—Diluted:                  
Earnings before extraordinary loss and cumulative effect of change in accounting principle   $ 1.04   $ 0.51   $ 0.58
Extraordinary loss, net of tax benefits     (0.06 )   (0.32 )  
Cumulative effect of change in accounting principle, net of tax benefits     (0.19 )      
   
 
 
  Net earnings   $ 0.79   $ 0.19   $ 0.58
   
 
 

        Basic EPS excludes all potentially dilutive securities. Basic EPS is computed by dividing net earnings by the weighted average number of common shares outstanding for the period. Diluted EPS includes all potentially dilutive securities. Diluted EPS is computed by dividing net earnings, adjusted by the if-converted method for convertible securities, by the weighted average number of common shares outstanding for the period plus the number of additional common shares that would have been outstanding if the dilutive securities were issued. In the event the dilutive securities are anti-dilutive (has the affect of increasing EPS), the impact of the dilutive securities is not included in the computation. In fiscal 2001, the Convertible Notes were anti-dilutive.

F-40


15. Leases

        Our leases are primarily for buildings, manufacturing equipment, automobiles and information technology equipment. Future minimum payments under non-cancelable operating leases, with initial terms exceeding one year, for fiscal years ending after December 28, 2002 are as follows: $10.6 million in 2003, $8.5 million in 2004, $5.1 million in 2005, $3.3 million in 2006, $1.4 million in 2007 and $3.2 million in later years.

        Rent expense for operating leases amounted to $13.1 million, $12.4 million, and $10.8 million for fiscal 2002, 2001 and 2000, respectively.

16. Pension and Other Postretirement Benefits

        Defined Benefit Pension Plans—Substantially all of our U.S. hourly and most of our Canadian employees participate in pension plans. At December 28, 2002, approximately 1,430 participants were covered by these plans and approximately 320 of them were receiving benefits.

        Changes in pension benefits, which are retroactive to previous service of employees, and gains and losses on pension assets, that occur because actual experience differs from assumptions, are amortized over the estimated average future service period of employees. Actuarial assumptions for the plans include:

        The pension plans assets are invested primarily in equity and fixed income mutual funds, marketable equity securities, insurance contracts, and cash and cash equivalents.

        Net pension expense (benefit) for fiscal 2002, 2001 and 2000 is included in selling, general and administrative expenses in the Consolidated Statements of Earnings and includes the following components (in thousands):

 
  Twelve Months Ended
 
Net Pension Expense

  December 28,
2002

  December 29,
2001

  December 30,
2000

 
Service cost—benefits earned during the period   $ 1,264   $ 1,244   $ 1,068  
Interest cost on projected benefit obligation     2,809     2,744     2,535  
Expected return on plan assets     (4,358 )   (5,237 )   (6,020 )
Amortization of prior service cost     55     81     95  
Amortization of unrecognized net gain     (7 )   (567 )   (1,958 )
Loss due to curtailments     320          
Amortization of transition gain     29     28     (40 )
   
 
 
 
  Net pension expense (benefit)   $ 112   $ (1,707 ) $ (4,320 )
   
 
 
 

F-41


        Reconciliation's of the change in benefit obligation, change in plan assets, and the funded status of the plans for fiscal 2002 and 2001 are as follows (in thousands):

Change in Benefit Obligation

  December 28,
2002

  December 29,
2001

 
Benefit obligation at beginning of year   $ 41,155   $ 36,601  
Service cost     1,264     1,244  
Interest cost     2,809     2,744  
Actuarial loss     978     2,439  
Benefits paid     (1,806 )   (1,737 )
Special termination benefits     (70 )    
Foreign currency exchange rate changes     50     (136 )
   
 
 
  Benefit obligation at end of year   $ 44,380   $ 41,155  
   
 
 
Change in Plan Assets
             
Fair value of plan assets at beginning of year   $ 50,858   $ 55,117  
Actual return on plan assets     (6,055 )   (2,229 )
Benefits paid     (1,806 )   (1,737 )
Foreign currency exchange rate changes     50     (293 )
   
 
 
  Fair value of plan assets at end of year   $ 43,047   $ 50,858  
   
 
 
Reconciliation of the Funded Status
             
Funded status   $ (1,333 ) $ 9,703  
Unrecognized transition asset     379     404  
Unrecognized prior service cost     3     445  
Unrecognized actuarial loss (gain)     9,677     (1,725 )
   
 
 
  Prepaid benefit cost   $ 8,726   $ 8,827  
   
 
 

        Postretirement Benefits Other than Pensions—We provide postretirement health care and life insurance benefits to certain U.S. retirees. These plans require employees to share in the costs. Practically all of the U.S. personnel would become eligible for these postretirement health care and life insurance benefits if they were to retire from the Company.

F-42


        The components of the postretirement net periodic expense, which is included in operating earning in the Consolidated Statements of Earnings for fiscal 2002, 2001, and 2000, are as follows (in thousands):

 
  Twelve Months Ended
Net Periodic Postretirement Expense

  December 28,
2002

  December 29,
2001

  December 30,
2000

Service cost—benefits earned during the period   $ 792   $ 580   $ 504
Interest cost on accumulated benefit obligation     1,358     1,129     1,013
Amortization of prior service cost     (94 )   (95 )   217
Recognized actuarial loss     403     269     73
   
 
 
  Net periodic postretirement expense   $ 2,459   $ 1,883   $ 1,807
   
 
 

        Reconciliation's of the change in benefit obligation, change in plan assets, and the funded status of the plan for fiscal 2002 and 2001 are as follows (in thousands):

Change in Benefit Obligation

  December 28,
2002

  December 29,
2001

 
Benefit obligation at beginning of year   $ 17,000   $ 14,755  
Service cost     792     580  
Interest cost     1,358     1,129  
Employee contributions     311     182  
Actuarial loss     4,714     1,198  
Benefits paid     (1,120 )   (844 )
   
 
 
  Benefit obligation at end of year   $ 23,055   $ 17,000  
   
 
 
Change in Plan Assets

   
   
 
Fair value of plan assets at beginning of year   $   $  
Employer contributions     809     662  
Employee contributions     311     182  
Benefits paid     (1,120 )   (844 )
   
 
 
  Fair value of plan assets at end of year   $   $  
   
 
 
Reconciliation of the Funded Status

   
   
 
Funded status   $ (23,055 ) $ (17,000 )
Unrecognized prior service gain     (712 )   (806 )
Unrecognized actuarial loss     10,022     5,711  
   
 
 
  Net amount accrued at year-end   $ (13,745 ) $ (12,095 )
   
 
 

F-43


        The assumed health care cost trend rate and discount rate were 9.0% and 7.25% in 2002, respectively compared to 9.5% and 7.50% in 2001, respectively. The assumed health care cost trend rate is anticipated to trend down until the final trend rate of 5.0% is reached in 2010. A one percentage point increase in the assumed health care costs trend rate increases the sum of the service and interest costs components of the fiscal 2002 net periodic postretirement benefit expense by 19%, and the accumulated postretirement benefit obligation as of December 28, 2002 by 15%. A one percentage point decrease in the assumed health care costs trend rate decreases the sum of the service and interest costs components of the fiscal 2002 net periodic postretirement benefit expense by 15% and the accumulated postretirement benefit obligation by 13%.

        Defined Contribution Benefit Plans—We also provide four defined contribution plans covering various employee groups, two of which have non-contributory features. The amounts charged to earnings for the defined contribution plans totaled $6.7 million, $5.8 million and $5.9 million for our last three fiscal years ended 2002, 2001, and 2000.

17. Business and Credit Concentrations

        Most of our customers are dispersed throughout the United States and Canada. No single customer accounted for more than 10% of our consolidated net sales in fiscal 2002, 2001, or 2000 with the exception of our largest customer (approximately 25% in 2002, 23% in 2001 and in 2000). Outstanding trade accounts receivable, including balances sold to Playtex A/R LLC, related to transactions with our largest customer were $25.1 million at December 28, 2002 and $29.4 million at December 29, 2001. Outstanding trade accounts receivable, including balances sold to Playtex A/R LLC, related to transactions with our customers ranked second through tenth in net sales, ranged from $8.6 million to $2.9 million at December 28, 2002 and ranged from $9.2 million to $3.9 million at December 29, 2001. Sales to these customers were made primarily from our two largest business segments.

F-44


18. Disclosure about the Fair Value of Financial Instruments

        Cash, Receivables, Retained Interest in Receivables, Accounts Payable, Income Taxes and Accrued Expenses—The carrying amounts approximate fair value because of the short-term nature of these instruments.

        Variable Rate Debt—The carrying amounts approximate fair value because the rate of interest on borrowings under the credit agreement is, at our option, a function of various alternative short-term borrowing rates.

        Long-term Debt and Other Financial Instruments—The fair value of the following financial instruments was estimated at December 28, 2002 and December 29, 2001 as follows (in thousands):

 
  December 28, 2002
  December 29, 2001
 
  Carrying
Amount

  Estimated
Fair Value

  Carrying
Amount

  Estimated
Fair Value

93/8% Senior Subordinated Notes(a)   $ 350,000   $ 381,500   $ 350,000   $ 369,250
6% Convertible Subordinated Notes due 2004(b)     30,000     31,060     50,000     50,880
15% Notes due from Playtex Apparel Partners, L.P.(c)     80,017     80,017     80,017     80,017
151/2% Subordinated Notes due to Playtex Apparel Partners, L.P.(c)     78,386     78,386     78,386     78,386
Other noncurrent assets(d)     9,712     9,659     9,942     9,914
Noncurrent liabilities(d)     14,526     14,503     13,146     13,115

(a)
The estimated fair value was based on quotes provided by independent securities dealers.

(b)
The estimated fair value was based on the net present value of the interest and principal payments.

(c)
The estimated fair values were based on the amount of future cash flows associated with these instruments, discounted using an appropriate interest rate.

(d)
The estimated fair values were based on a combination of actual cost associated with recent purchases or the amount of future cash flows discounted using our borrowing rate for similar instruments.

F-45


19. Quarterly Data (Unaudited)

        The following is a summary of our quarterly results of operations and market price data for our common stock for fiscal 2002 and 2001 (in thousands, except per share data):

Fiscal 2002

  First
Quarter

  Second
Quarter

  Third
Quarter

  Fourth
Quarter

Net sales   $ 196,751   $ 201,552   $ 161,567   $ 159,217
Gross profit     111,040     113,841     85,495     80,278
Operating earnings     39,481     48,467     28,760     24,799
Earnings before extraordinary loss and cumulative effect of change in accounting principle     28,540     20,473     8,886     7,163
Net earnings     16,117     16,738     8,886     7,163
Earnings before extraordinary loss and cumulative effect of change in accounting principle(a):                        
  Basic   $ 0.47   $ 0.33   $ 0.15   $ 0.12
  Diluted   $ 0.45   $ 0.32   $ 0.14   $ 0.12
Earnings per share(a):                        
  Basic   $ 0.26   $ 0.27   $ 0.15   $ 0.12
  Diluted   $ 0.26   $ 0.27   $ 0.14   $ 0.12
Stock market price                        
  High   $ 11.14   $ 14.25   $ 13.04   $ 11.00
  Low   $ 9.60   $ 10.50   $ 8.48   $ 6.95
Fiscal 2001

  First
Quarter

  Second
Quarter

  Third
Quarter

  Fourth
Quarter

Net sales   $ 199,616   $ 198,444   $ 158,800   $ 166,658
Gross profit     110,713     110,590     83,286     85,122
Operating earnings     43,384     42,261     23,699     24,647
Earnings before extraordinary loss     12,844     12,129     2,356     3,552
Net earnings (loss)     12,844     (7,207 )   2,356     3,552
Earnings per share before extraordinary loss(a):                        
  Basic   $ 0.21   $ 0.20   $ 0.04   $ 0.06
  Diluted   $ 0.21   $ 0.20   $ 0.04   $ 0.06
Earnings per share(a):                        
  Basic   $ 0.21   $ (0.12 ) $ 0.04   $ 0.06
  Diluted   $ 0.21   $ (0.11 ) $ 0.04   $ 0.06
Stock market price                        
  High   $ 10.35   $ 11.20   $ 10.80   $ 10.46
  Low   $ 7.93   $ 8.55   $ 9.60   $ 9.30

(a)
Earnings per share data are computed independently for each of the periods presented. As a result, the sum of the earnings per share amounts for the quarters may not equal the total for the year.

F-46


20. Condensed Consolidating Financial Information

93/8% Senior Subordinated Notes due 2011

        The 93/8% Notes are guaranteed by the following wholly-owned subsidiaries:

        The guarantors are joint and several guarantors of the 93/8% Notes. Such guarantees are irrevocable, full and unconditional. The guarantees are senior subordinated obligations and are subordinated to all senior obligations including guarantees of our obligations under the Credit Agreement.

        The following wholly-owned subsidiaries are non guarantors of the 93/8% Notes:

        The following information, presents our condensed consolidating financial position as of December 28, 2002 and December 29, 2001 and our condensed consolidating statements of earnings and cash flows for each of our last three fiscal years 2002, 2001, and 2000. The presentation is made based on:

  the Company on a consolidated basis,     the combined guarantors, and
  the parent company only,     the combined non-guarantors.

F-47


Condensed Consolidating Balance Sheet Data
as of December 28, 2002
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Assets                                
Current assets   $ 300,203   $ (492 ) $ 111,207   $ 167,852   $ 21,636  
Investment in subsidiaries         (486,087 )   472,329     13,758      
Intercompany receivable         (113,943 )       113,943      
Net property, plant and equipment     121,199         129     120,481     589  
Intangible assets     633,481         440,529     192,952      
Other noncurrent assets     23,304         22,108     1,196      
   
 
 
 
 
 
  Total assets   $ 1,078,187   $ (600,522 ) $ 1,046,302   $ 610,182   $ 22,225  
   
 
 
 
 
 
Liabilities and Stockholders' Equity                                
Current liabilities   $ 185,277   $ (492 ) $ 174,514   $ 7,258   $ 3,997  
Intercompany payable         (113,943 )   28,014     81,812     4,117  
Long-term debt     823,250         823,250          
Other noncurrent liabilities     64,127         14,991     49,508     (372 )
   
 
 
 
 
 
  Total liabilities     1,072,654     (114,435 )   1,040,769     138,578     7,742  
Stockholders' equity     5,533     (486,087 )   5,533     471,604     14,483  
   
 
 
 
 
 
  Total liabilities and stockholders' equity   $ 1,078,187   $ (600,522 ) $ 1,046,302   $ 610,182   $ 22,225  
   
 
 
 
 
 

Condensed Consolidating Balance Sheet Data
as of December 29, 2001
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Assets                                
Current assets   $ 218,818   $ 9   $ 114,504   $ 87,001   $ 17,304  
Investment in subsidiaries         (478,436 )   465,246     13,190      
Intercompany receivable         (97,403 )       96,338     1,065  
Net property, plant and equipment     124,761         88     123,983     690  
Intangible assets     653,703         440,598     213,105      
Due from related party     80,017     (500 )       80,517      
Other noncurrent assets     27,873         27,873          
   
 
 
 
 
 
  Total assets   $ 1,105,172   $ (576,330 ) $ 1,048,309   $ 614,134   $ 19,059  
   
 
 
 
 
 
Liabilities and Stockholders' Equity                                
Current liabilities   $ 111,038   $ 16   $ 101,916   $ 5,631   $ 3,475  
Intercompany payable         (97,403 )   479     94,122     2,802  
Long-term debt     888,800         888,800          
Due to related party     78,386     (507 )   78,893          
Other noncurrent liabilities     71,518         22,791     49,135     (408 )
   
 
 
 
 
 
  Total liabilities     1,149,742     (97,894 )   1,092,879     148,888     5,869  
Stockholders' equity     (44,570 )   (478,436 )   (44,570 )   465,246     13,190  
   
 
 
 
 
 
  Total liabilities and stockholders' equity   $ 1,105,172   $ (576,330 ) $ 1,048,309   $ 614,134   $ 19,059  
   
 
 
 
 
 

F-48


Condensed Consolidating Statement of Earnings Data
For the Twelve Months Ended December 28, 2002
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Net revenues   $ 719,087   $ (432,759 ) $ 685,595   $ 425,728   $ 40,523  
Cost of sales     328,433     (323,783 )   318,956     307,459     25,801  
   
 
 
 
 
 
  Gross profit     390,654     (108,976 )   366,639     118,269     14,722  
   
 
 
 
 
 
Operating expenses:                                
Selling, general and administrative     240,620     (108,976 )   255,582     82,074     11,940  
Restructuring and asset impairment     7,599         3,799     3,800      
Amortization of intangibles     928         95     833      
   
 
 
 
 
 
  Total operating expenses     249,147     (108,976 )   259,476     86,707     11,940  
   
 
 
 
 
 
  Operating earnings     141,507         107,163     31,562     2,782  
Interest expense, net     59,543         71,620     (12,003 )   (74 )
Other expense     2,653         2,653          
Equity in net earnings of subsidiaries         17,249     (15,821 )   (1,428 )    
   
 
 
 
 
 
  Earnings before income taxes     79,311     (17,249 )   48,711     44,993     2,856  
Income taxes     14,249         (3,928 )   17,274     903  
   
 
 
 
 
 
  Earnings before extraordinary loss and change in accounting principle     65,062     (17,249 )   52,639     27,719     1,953  
   
 
 
 
 
 
Extraordinary loss, net of tax     (3,735 )       (3,735 )        
Cumulative effect of change in accounting principle     (12,423 )           (12,423 )    
   
 
 
 
 
 
  Net earnings   $ 48,904   $ (17,249 ) $ 48,904   $ 15,296   $ 1,953  
   
 
 
 
 
 

Condensed Consolidating Statement of Earnings Data
For the Twelve Months Ended December 29, 2001
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Net revenues   $ 723,518   $ (424,978 ) $ 688,819   $ 419,503   $ 40,174  
Cost of sales     333,807     (291,635 )   292,836     307,894     24,712  
   
 
 
 
 
 
  Gross profit     389,711     (133,343 )   395,983     111,609     15,462  
   
 
 
 
 
 
Operating expenses:                                
Selling, general and administrative     233,660     (133,343 )   276,924     77,526     12,553  
Amortization of intangibles     22,060         15,447     6,613      
   
 
 
 
 
 
  Total operating expenses     255,720     (133,343 )   292,371     84,139     12,553  
   
 
 
 
 
 
  Operating earnings     133,991         103,612     27,470     2,909  
Interest expense, net     75,861         88,134     (12,003 )   (270 )
Other expense     2,103         2,103          
Equity in net earnings of subsidiaries         28,171     (26,022 )   (2,149 )    
   
 
 
 
 
 
  Earnings before income taxes     56,027     (28,171 )   39,397     41,622     3,179  
Income taxes     25,146         8,516     15,600     1,030  
   
 
 
 
 
 
  Earnings before extraordinary loss     30,881     (28,171 )   30,881     26,022     2,149  
   
 
 
 
 
 
Extraordinary loss, net of tax     (19,336 )       (19,336 )        
   
 
 
 
 
 
  Net earnings   $ 11,545   $ (28,171 ) $ 11,545   $ 26,022   $ 2,149  
   
 
 
 
 
 

F-49


Condensed Consolidating Statement of Earnings Data
For the Twelve Months Ended December 30, 2000
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Net revenues   $ 733,363   $ (432,931 ) $ 697,226   $ 429,371   $ 39,697  
Cost of sales     334,983     (315,110 )   322,509     303,503     24,081  
   
 
 
 
 
 
  Gross profit     398,380     (117,821 )   374,717     125,868     15,616  
   
 
 
 
 
 
Operating expenses:                                
Selling, general and administrative     228,093     (117,821 )   242,688     92,059     11,167  
Amortization of intangibles     22,350         15,430     6,920      
   
 
 
 
 
 
  Total operating expenses     250,443     (117,821 )   258,118     98,979     11,167  
   
 
 
 
 
 
  Operating earnings     147,937         116,599     26,889     4,449  
Interest expense, net     84,884         97,213     (12,003 )   (326 )
Equity in net earnings of subsidiaries         29,255     (26,129 )   (3,126 )    
   
 
 
 
 
 
  Earnings before income taxes     63,053     (29,255 )   45,515     42,018     4,775  
Income taxes     27,509         9,971     15,889     1,649  
   
 
 
 
 
 
  Net earnings   $ 35,544   $ (29,255 ) $ 35,544   $ 26,129   $ 3,126  
   
 
 
 
 
 

F-50



Condensed Consolidating Statement of Cash Flows Data
For the Twelve Months Ended December 28, 2002
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Net earnings   $ 48,904   $ (17,249 ) $ 48,904   $ 15,296   $ 1,953  
  Non-cash items included in earnings:                                
    Cumulative effect of change in accounting principle, net of tax     12,423             12,423      
    Asset impairment charge     4,222         2,111     2,111      
    Extraordinary loss, net of tax     3,735         3,735          
    Amortization of intangibles     928         95     833      
    Amortization of deferred financing costs     2,138         2,138          
    Depreciation     14,011         16     13,735     260  
    Deferred taxes     2,342         (4,897 )   7,203     36  
    Other, net     2,530     17,249     (13,291 )   (1,428 )    
  Increase (decrease) in net working capital     (13,334 )       (16,882 )   4,573     (1,025 )
  Increase in amounts due to Parent             27,534     (29,914 )   2,380  
   
 
 
 
 
 
      Net cash flows from operations     77,899         49,463     24,832     3,604  
Cash flows used for investing activities:                                
  Purchases of property, plant and equipment     (16,445 )       (57 )   (16,237 )   (151 )
  Businesses and intangible assets acquired, net     (975 )   200     (225 )   (950 )    
   
 
 
 
 
 
      Net cash flows used for investing activities     (17,420 )   200     (282 )   (17,187 )   (151 )
Cash flows used for financing activities:                                
  Net borrowings under working capital credit facilities     (17,000 )       (17,000 )        
  Long-term debt borrowings     450,000         450,000          
  Long-term debt repayments     (494,050 )       (494,050 )        
  Payment of financing costs     (3,681 )       (3,681 )        
  Issuance of shares of common stock, net     1,851     (200 )   1,851         200  
  Receipt (payment) of dividends             8,813     (7,645 )   (1,168 )
   
 
 
 
 
 
      Net cash flows used for financing activities     (62,880 )   (200 )   (54,067 )   (7,645 )   (968 )
Decrease in cash     (2,401 )       (4,886 )       2,485  
Cash at beginning of period     34,006     8     26,698     1     7,299  
   
 
 
 
 
 
Cash at end of period   $ 31,605   $ 8   $ 21,812   $ 1   $ 9,784  
   
 
 
 
 
 

F-51


Condensed Consolidating Statement of Cash Flows Data
For the Twelve Months Ended December 29, 2001
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Net earnings   $ 11,545   $ (28,171 ) $ 11,545   $ 26,022   $ 2,149  
  Non-cash items included in earnings:                                
    Extraordinary loss, net of tax     19,336         19,336          
    Amortization of intangibles     22,060         15,447     6,613      
    Amortization of deferred financing costs     2,923         2,923          
    Depreciation     13,140         32     12,812     296  
    Deferred taxes     12,902         5,757     7,150     (5 )
    Other, net     (1,016 )   28,171     (27,038 )   (2,149 )    
  Increase (decrease) in net working capital     46,045         45,267     2,402     (1,624 )
  Increase in amounts due to Parent             23,437     (24,869 )   1,432  
   
 
 
 
 
 
      Net cash flows from operations     126,935         96,706     27,981     2,248  
Cash flows used for investing activities:                                
  Purchases of property, plant and equipment     (19,950 )       (2 )   (19,836 )   (112 )
  Businesses and intangible asset acquired, net     (500 )           (500 )    
   
 
 
 
 
 
      Net cash flows used for investing activities     (20,450 )       (2 )   (20,336 )   (112 )
Cash flows used for financing activities:                                
  Net borrowings under working capital credit facilities     17,000         17,000          
  Long-term debt borrowings     850,000         850,000          
  Long-term debt repayments     (909,763 )       (909,763 )        
  Payment of debt extinguishment fees     (21,177 )       (21,177 )        
  Payment of financing costs     (19,500 )       (19,500 )        
  Issuance of shares of common stock, net     679         679          
  Receipt (payment) of dividends             8,365     (7,645 )   (720 )
   
 
 
 
 
 
      Net cash flows used for financing activities     (82,761 )       (74,396 )   (7,645 )   (720 )
Increase in cash     23,724         22,308         1,416  
Cash at beginning of period     10,282     8     4,390     1     5,883  
   
 
 
 
 
 
Cash at end of period   $ 34,006   $ 8   $ 26,698   $ 1   $ 7,299  
   
 
 
 
 
 

F-52


Condensed Consolidating Statement of Cash Flows Data
For the Twelve Months Ended December 30, 2000
(In thousands)

 
  Consolidated
  Eliminations
  Parent
Company

  Guarantors
  Non-
Guarantors

 
Net earnings   $ 35,544   $ (29,255 ) $ 35,544   $ 26,129   $ 3,126  
  Non-cash items included in earnings:                                
    Amortization of intangibles     22,350         15,430     6,920      
    Amortization of deferred financing costs     3,750         3,750          
    Depreciation     11,547         63     11,177     307  
    Deferred taxes     11,383         3,930     7,453      
    Other, net     (3,214 )   29,255     (28,992 )   (2,968 )   (509 )
  Increase (decrease) in net working capital     (2,634 )       (1,011 )   (1,545 )   (78 )
  Increase (decrease) in amounts due to Parent             18,600     (17,325 )   (1,275 )
   
 
 
 
 
 
      Net cash flows from operations     78,726         47,314     29,841     1,571  
Cash flows used for investing activities:                                
  Purchases of property, plant and equipment     (22,724 )       (243 )   (22,196 )   (285 )
  Businesses acquired, net     (279 )       (279 )        
   
 
 
 
 
 
      Net cash flows used for investing activities     (23,003 )       (522 )   (22,196 )   (285 )
Cash flows used for financing activities:                                
  Net payments under working capital facilities and long-term debt obligations     (56,313 )       (56,313 )        
  Payment of financing costs     (553 )       (553 )        
  Issuance of shares of common stock, net     3,899         3,899          
  Receipt (payment) of dividends             8,713     (7,645 )   (1,068 )
   
 
 
 
 
 
      Net cash flows used for financing activities     (52,967 )       (44,254 )   (7,645 )   (1,068 )
Increase in cash     2,756         2,538         218  
Cash at beginning of period     7,526     8     1,852     1     5,665  
   
 
 
 
 
 
Cash at end of period   $ 10,282   $ 8   $ 4,390   $ 1   $ 5,883  
   
 
 
 
 
 

F-53


PLAYTEX PRODUCTS, INC.
INDEPENDENT AUDITORS' REPORT

The Board of Directors and Stockholders
Playtex Products, Inc.:

        We have audited the accompanying consolidated balance sheets of Playtex Products, Inc. and subsidiaries as of December 28, 2002 and December 29, 2001, and the related consolidated statements of earnings, stockholders' equity and comprehensive earnings, and cash flows for the twelve months ended December 28, 2002, December 29, 2001, and December 30, 2000, included on pages F-18 through F-53 in the Company's 2002 Annual Report on Form 10-K. In connection with our audits of the consolidated financial statements, we also have audited the related consolidated financial statement schedule, included on page 26 in the Company's 2002 Annual Report on Form 10-K. These consolidated financial statements and financial statement schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.

        We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

        In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidateds financial position of Playtex Products, Inc. and subsidiaries as of December 28, 2002 and December 29, 2001, and the results of their operations and their cash flows for the twelve months ended December 28, 2002, December 29, 2001, and December 30, 2000, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the related financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

        As disclosed in Note 2 to the consolidated financial statements, the Company adopted Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets," and Emerging Issues Task Force Issue No. 01-09, "Accounting for Consideration Given by a Vendor to a Customer (Including a Reseller of the Vendor's Products)," as of December 30, 2001.

/S/ KPMG LLP

January 27, 2003
Stamford, Connecticut

F-54



PLAYTEX PRODUCTS, INC.
REPORT OF MANAGEMENT

        The management of Playtex Products, Inc. is responsible for the financial and operating information contained in the Annual Report, including the financial statements covered by the independent auditors' report. These statements were prepared in conformity with accounting principles generally accepted in the United States of America and include, where necessary, informed estimates and judgments.

        The Company maintains systems of accounting and internal control designed to provide reasonable assurance that assets are safeguarded against loss, and transactions are executed and recorded properly so as to ensure that the financial records are reliable for preparing financial statements.

        Elements of these control systems are the establishment and communication of accounting and administrative policies and procedures, the selection and training of qualified personnel, and continuous programs of internal review.

        The Company's financial statements are reviewed by its Audit Committee, which is composed entirely of non-employee Directors. This Committee meets with the independent auditors and management to review the scope and results of the annual audit, interim reviews, internal controls, and financial reporting matters. The independent auditors have direct access to the Audit Committee.

/S/ MICHAEL R. GALLAGHER
Chief Executive Officer
and Director

/S/ GLENN A. FORBES
Executive Vice President,
Chief Financial Officer
and Director

January 27, 2003
Westport, Connecticut

F-55



PLAYTEX PRODUCTS, INC.
OTHER INFORMATION

Corporate Information

        Our common stock is traded on the New York Stock Exchange under the symbol PYX. We do not pay dividends on our common stock and it is our policy to retain earnings for use in our business. Under our debt agreements, we are restricted from paying dividends unless we meet certain specified financial criteria immediately following such payment.

        We will send you, at no charge, a copy of our fiscal 2002 Annual Report on Form 10-K, upon your written request to our Investor Relations Department at our Corporate Offices. If you wish, you may call Playtex Products, Inc. Investor Relations at (203) 341- 4017 or via email at invrel@playtex.com.

        This document is also included in our filings with the Securities and Exchange Commission which are made electronically through its EDGAR system and are available to the public at the SEC's website—www.sec.gov. Additionally, we make our filings with the SEC available at the Investors Relations section of our website www.playtexproductsinc.com.

Stock Transfer Agent and Registrar
Playtex Products, Inc.
c/o Mellon Investor Services LLC
P.O. Box 3315
South Hackensack, New Jersey 07606
(800) 851-9677
www.melloninvestor.com

Independent Auditors
KPMG LLP
3001 Summer Street
Stamford, CT 06905

Corporate Offices
Playtex Products, Inc.
300 Nyala Farms Road
Westport, CT 06880

F-56


Board of Directors

 
Robert B. Haas

 

Chairman of the Board of Playtex Products, Inc. and Chairman of the Board and Chief Executive Officer of Haas Wheat & Partners, L.P.
 
Michael R. Gallagher

 

Chief Executive Officer
 
Glenn A. Forbes

 

Executive Vice President and Chief Financial Officer
 
Richard C. Blum

 

Chairman of the Board and President of Richard C. Blum & Associates, Inc.
 
Michael R. Eisenson

 

President and Chief Executive Officer of Charlesbank Capital Partners, LLC
 
R. Jeffrey Harris

 

Of Counsel and Director of Apogent Technologies, Inc.
 
C. Ann Merrifield

 

Executive Vice President, Genzyme Biosurgery
 
Susan R. Nowakowski

 

Chief Operating Officer and Executive Vice President, AMN Healthcare Services, Inc.
 
John C. Walker

 

Partner, BLUM Capital Partners, L.P.
 
Wyche H. Walton

 

Senior Vice President of Haas Wheat & Partners, L.P.
 
Douglas D. Wheat

 

President of Haas Wheat & Partners, L.P.

Principal Officers

 

 
 
Michael R. Gallagher

 

Chief Executive Officer
 
Glenn A. Forbes

 

Executive Vice President and Chief Financial Officer
 
Kevin M. Dunn

 

President, Consumer Products Division
 
John D. Leahy

 

President, International/Corporate Sales Division
 
Richard G. Powers

 

President, Personal Products Division
 
James S. Cook

 

Senior Vice President, Operations
 
Paul A. Siracusa

 

Senior Vice President, Research and Development
 
Frank M. Sanchez

 

Vice President, Human Resources
 
Vincent S. Viviani

 

Vice President, Quality Systems
 
Paul E. Yestrumskas

 

Vice President, General Counsel and Secretary

F-57



PLAYTEX PRODUCTS, INC.
INDEX TO EXHIBITS

Exhibit No.

  Description

3

(a)

Restated Certificate of Incorporation, as amended through June 6, 1995. (Incorporated herein by reference to Exhibit 3.2 of Playtex's Form 8-K, dated June 6, 1995.)

3

(b)

By-laws of the Company, as amended through May 31, 2001. (Incorporated herein by reference to Exhibit 3 of Playtex's Form 10-Q for the period ended June 30, 2001, dated August 14, 2001.)

4

(a)

Indenture dated, May 22, 2001 relating to the 93/8% Senior Subordinated Notes due 2011 (the "Senior Subordinated Notes") among Playtex Products, Inc., as issuer, Playtex Sales & Services, Inc., Playtex Manufacturing, Inc., Playtex Investment Corp., Playtex International Corp., TH Marketing Corp., Smile-Tote, Inc., Sun Pharmaceuticals Corp., Personal Care Group, Inc., Personal Care Holdings, Inc., and Carewell Industries, Inc., as Guarantors and the Bank of New York, as Trustee. (Incorporated herein by reference to Exhibit 4.1 of Playtex's Registration Statement on Form S-4 dated June 28, 2001, File No. 333-64070-03.)

4

(a)(1)

Registration Rights Agreement relating to the Senior Subordinated Notes among Playtex Products, Inc., as issuer, the guarantors named therein, Credit Suisse First Boston Corporation and Wells Fargo Brokerage Services, LLC (the "Initial Purchasers"). (Incorporated herein by reference to Exhibit 4.2 of Playtex's Registration Statement on Form S-4 dated June 28, 2001, File No. 333-64070-03.)

4

(b)

Form of Junior Subordinated Note of Playtex. (Incorporated herein by reference to Exhibit 4(i) of Playtex's Registration Statement on Form S-1, File No. 33-25485.)

4

(b)(1)

Form of Junior Subordinated Note of Playtex dated December 15, 1989. (Incorporated herein by reference to Exhibit 4(f)(1) of Playtex's Annual Report on Form 10-K for the year ended December 30, 1989.)

4

(b)(2)

Junior Subordinated Note of Playtex dated December 15, 1990. (Incorporated herein by reference to Exhibit 4(f)(2) of Playtex's Annual Report on Form 10-K for the year ended December 29, 1990.)

4

(b)(3)

Junior Subordinated Note of Playtex dated December 15, 1991. (Incorporated herein by reference to Exhibit 4(h)(3) of Playtex's Registration Statement on Form S-1, No. 33-43771.)

4

(b)(4)

Junior Subordinated Note of Playtex dated December 15, 1992. (Incorporated herein by reference to Exhibit 4(h)(4) of Playtex's Annual Report on Form 10-K for the year ended December 26, 1992.)

4

(b)(5)

Junior Subordinated Note of Playtex dated December 15, 1993. (Incorporated herein by reference to Exhibit 4(j)(5) of Playtex's Registration Statement on Form S-1, No. 33-71512.)

4

(b)(6)

Agreement between Playtex and Playtex Apparel Partners, L.P. dated November 30, 1994 relating to Junior Subordinated Notes. (Incorporated herein by reference to Exhibit 4(d)(6) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 31, 1994.)

4

(c)

Indenture relating to the 6% Convertible Notes, dated as of January 29, 1999, between Playtex Products, Inc. and Marine Midland Bank. (Incorporated herein by reference to Exhibit 2.2 of Playtex's Form 8-K, dated February 12, 1999.)

 

 

 

X-1



10

(a)

Credit Agreement, dated as of May 22, 2001, among Playtex Products, Inc., Credit Suisse First Boston, as the Administrative Agent, and the lenders from time to time parties to the Credit Agreement. (Incorporated herein by reference to Exhibit 10.1 of Playtex's Registration Statement on Form S-4 dated June 28, 2001, File No. 333-64070-03.)

10

(a)(1)

First Amendment to the Credit Agreement, dated as of May 29, 2002, among Playtex Products, Inc., Credit Suisse First Boston, as the Administrative Agent, and the lenders from time to time parties to the Credit Agreement. (Incorporated herein by reference to Exhibit 10.1 of Playtex's Form 8-K, dated May 31, 2002.)

10

(b)

Receivables Purchase Agreement, dated as of May 22, 2001, among Playtex Products, Inc., Credit Suisse First Boston, New York Branch, Playtex A/R LLC, and Gramercy Capital Corporation. (Incorporated herein by reference to Exhibit 10.2 of Playtex's Registration Statement on Form S-4 dated June 28, 2001, File No. 333-64070-03.)

10

(c)

Purchase and Contribution Agreement, dated as of May 22, 2001, between Playtex Products, Inc., and Playtex A/R LLC. (Incorporated herein by reference to Exhibit 10.3 of Playtex's Registration Statement on Form S-4 dated June 28, 2001, File No. 333-64070-03.)

10

(d)

Consulting Agreement between Family Products and Joel E. Smilow, dated January 30, 1993. (Incorporated herein by reference to Exhibit 10(m) of Playtex's Registration Statement on Form S-1, No. 33-71512.)

10

(d)(1)

First Amendment to the Consulting Agreement, dated as of August 17, 1999, between Playtex Products Inc., and Joel E. Smilow. (Incorporated herein by reference to Exhibit 10(c)(1) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 25, 1999.)

10

(e)

Deferred Benefit Equalization Plan dated August 15, 1977, as amended April 15, 1987. (Incorporated herein by reference to Exhibit 10(e) of Playtex Holding's Annual Report on Form 10-K for the year ended December 28, 1987.)

*10

(e)(1)

Deferred Benefit Equalization Plan, amended and restated effective January 1, 2002.

*10

(e)(2)

Amendment 2003-1 to the Deferred Benefit Equalization Plan, dated February 27, 2003.

10

(f)

Playtex Management Incentive Plan. (Incorporated herein by reference to Exhibit 10(e) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

10

(g)

Playtex 1994 Stock Option Plan for Directors and Executive and Key Employees. (Incorporated herein by reference to Exhibit 10(hh) of Playtex's Registration Statement on Form S-1, No. 33-71512.)

10

(g)(1)

Amendment No. 1 to the 1994 Stock Option Plan. (Incorporated herein by reference to Exhibit 10.2 of Playtex's Form 8-K, dated June 6, 1995.)

10

(g)(2)

Amendment No. 2 to the 1994 Stock Option Plan. (Incorporated herein by reference to Exhibit 10.2 of Playtex's Form 8-K, dated June 6, 1995.)

 

 

 

X-2



10

(g)(3)

Amendment No. 3 to the 1994 Stock Option Plan. (Incorporated herein by reference to Exhibit 10.2 of Playtex's Form 8-K, dated June 6, 1995.)

10

(g)(4)

Amendment No. 4 to the 1994 Stock Option Plan. (Incorporated herein by reference to Exhibit 10.2 of Playtex's Form 8-K, dated June 6, 1995.)

10

(g)(5)

Amendment No. 5 to the 1994 Stock Option Plan. (Incorporated herein by reference to Exhibit 10(l)(5) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

10

(g)(6)

Amendment No. 6 to the 1994 Stock Option Plan. (Incorporated herein by reference to Exhibit 10(1)(6) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

10

(g)(7)

Playtex 1994 Stock Option Plan for Directors and Executive and Key Employees as amended through April 6, 1999. (Incorporated herein by reference to Exhibit 10(l) of Playtex's Form 10-Q for the period ended June 26, 1999, dated August 4, 1999.)

10

(g)(8)

Playtex 1994 Stock Option Plan for Directors and Executive and Key Employees as amended through April 2001. (Incorporated herein by reference to Exhibit 10(1) of Playtex's Form 10-Q for the period ended June 30, 2001, dated August 14, 2001.)

10

(h)

Memorandum of Understanding, dated June 21, 1995 with Michael R. Gallagher, Chief Executive Officer. (Incorporated herein by reference to Exhibit 10(ab) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 30, 1995.)

10

(h)(1)

Memorandum of Understanding, dated May 18, 1999 with Michael R. Gallagher, Chief Executive Officer. (Incorporated herein by reference to Exhibit 10(m) of Playtex's Form 10-Q for the period ended June 26, 1999, dated August 4, 1999.)

10

(i)

Form of Retention Agreement dated as of July 22, 1997 between Michael R. Gallagher and the Company. (Incorporated herein by reference to Exhibit 10.1 of Playtex's Registration Statement on Form S-4 dated August 29, 1997, File No. 333-33915.)

10

(j)

Form of Retention Agreement dated as of July 22, 1997 between each of, James S. Cook, John D. Leahy, Richard G. Powers, Frank M. Sanchez, and Paul E. Yestrumskas and the Company. (Incorporated herein by reference to Exhibit 10.3 of Playtex's Registration Statement on Form S-4 dated August 29, 1997, File No. 333-33915.)

10

(k)

Form of Retention Agreement dated as of March 13, 2000 between Paul A. Siracusa and the Company. (Incorporated herein by reference to Exhibit 10(j) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

10

(l)

Form of Retention Agreement dated as of March 21, 2000 between Glenn A. Forbes and the Company. (Incorporated herein by reference to Exhibit 10(k) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

*10

(l)(1)

Amended Form of Retention Agreement dated as of March 20, 2003 between Glenn A. Forbes and the Company.

 

 

 

X-3



10

(m)

Form of Retention Agreement dated as of August 1, 2000 between Kevin M. Dunn and the Company. (Incorporated herein by reference to Exhibit 10(l) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

10

(n)

Form of Retention Agreement dated as of August 1, 2000 between Vincent S. Viviani and the Company. (Incorporated herein by reference to Exhibit 10(m) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

*10

(o)

Amendment to Retention Agreements, dated as of March 21, 2003 between each of Michael R. Gallagher, James S. Cook, John D. Leahy, Richard G. Powers, Frank M. Sanchez, Paul E. Yestrumskas, Paul A. Siracusa, Kevin M. Dunn and Vincent S. Viviani and the Company.

10

(p)

Amended Trademark License Agreement dated November 19, 1991 among Marketing Corporation, Apparel and Family Products. (Incorporated herein by reference to Exhibit 10(r) of Playtex's Registration Statement on Form S-1, File No. 33-43771.)

10

(q)

Amended Trademark License Agreement dated November 19, 1991 by and between Apparel and Family Products. (Incorporated herein by reference to Exhibit 10(s) of Playtex's Registration Statement on Form S-1, File No. 33-43771.)

10

(r)

Release Agreement, dated November 5, 1991, between Playtex Investment Corp. and Playtex Apparel Partners, L.P. (Incorporated herein by reference to Exhibit 10(gg) of Playtex's Registration Statement on Form S-1, No. 33-71512.)

10

(s)

Stock Purchase Agreement dated as of March 17, 1995 between Playtex and HWH Capital Partners, L.P., HWH Valentine Partners, L.P. and HWH Surplus Valentine Partners, L.P. (Incorporated herein by reference to Exhibit 10.1 of Playtex's Form 8-K, dated March 17, 1995.)

10

(s)(1)

Amendment No.1 to Stock Purchase Agreement, dated as of June 1, 1998, by and among the Company, HWH Capital Partners, L.P., HWH Valentine Partners, L.P., HWH Surplus Valentine Partners, L.P. to the Stock Purchase Agreement, dated as of March 17, 1995. (Incorporated herein by reference to Exhibit 10(3) of Playtex's Post Effective Amendment No. 1 to Form S-3 dated as of June 12, 1998, File No. 333-50099.)

10

(s)(2)

First Amended and Restated Registration Rights Agreement, dated as of June 1, 1998, by and among the Company, HWH Capital Partners, L.P., HWH Valentine Partners, L.P., HWH Surplus Valentine Partners, L.P. to the Stock Purchase Agreement, dated as of March 17, 1995. (Incorporated herein by reference to Exhibit 10(5) of Playtex's Post Effective Amendment No. 1 to Form S-3 dated as of June 12, 1998, No. 333-50099.)

10

(s)(3)

Amendment No. 1, dated as of January 29, 1999 to the First Amended and Restated Registration Rights Agreement, dated as of March 17, 1995, as amended and restated as of June 1, 1998 by and among the Company, HWH Capital Partners, L.P., HWH Valentine Partners, L.P., HWH Surplus Valentine Partners, L.P. to the Stock Purchase Agreement. (Incorporated herein by reference to Exhibit 10(t)(3) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

 

 

 

X-4



10

(t)

Stock Purchase Agreement, dated as of December 19, 1997, among Playtex Products, Inc., and the Shareholders of Carewell Industries, Inc. (Incorporated herein by reference to Exhibit 10(af) of Playtex's Annual Report on Form 10-K for the year ended December 27, 1997.)

10

(u)

Asset Purchase Agreement, dated as of January 26, 1998, among Playtex Products, Inc., Binky-Griptight, Inc., Lewis Woolf Griptight Limited and L.W.G. Holdings Limited. (Incorporated herein by reference to Exhibit 10(ag) of Playtex's Annual Report on Form 10-K for the year ended December 27, 1997.)

10

(v)

Merger Agreement, dated as of December 22, 1997, among Playtex Products, Inc., PCG Acquisition Corp., J.W. Childs Equity Partners L.P. and Personal Care Holdings, Inc. (Incorporated herein by reference to Exhibit 2.1 of Playtex's Form 8-K, dated February 12, 1998.)

10

(w)

Asset Sale Agreement, dated as of May 13, 1999, by and between Playtex Products, Inc. and Colgate Palmolive Company. (Incorporated herein by reference to Exhibit 2.1 of Playtex's Current Report on Form 8-K, dated July 15, 1999.)

10

(w)(1)

Amendment No. 1 to the Asset Sale Agreement, dated as of June 25, 1999, by and between Playtex Products, Inc. and Colgate Palmolive Company. (Incorporated herein by reference to Exhibit 2.2 of Playtex's Current Report on Form 8-K, dated July 15, 1999.)

10

(x)

Registration Rights Agreement, dated as of January 28, 1998 among Playtex Products, Inc. and J.W. Childs Equity Partners, L.P. (Incorporated herein by reference to Exhibit 2.2 of Playtex's Form 8-K, dated February 12, 1998.)

10

(x)(1)

First Amended and Restated Registration Rights Agreement, dated as of June 1, 1998, by and among the Company, J.W. Childs Equity Partners, L.P and certain other Stockholders named in the Stockholders Agreement dated as of January 28, 1998. (Incorporated herein by reference to Exhibit 10(6) of Playtex's Post Effective Amendment No. 1 to Form S-3, dated as of June 12, 1998, File No. 333-50099.)

10

(y)

Stockholders Agreement, dated as of January 28, 1998, between Playtex Products, Inc. and J.W. Childs Equity Partners, L.P. and certain other Stockholders named therein. (Incorporated herein by reference to Exhibit 2.3 of Playtex's Form 8-K, dated February 12, 1998.)

10

(z)

Letter Agreement, dated as of June 1, 1998, by and among the Company, J.W. Childs Equity Partners, L.P and certain other Stockholders named in the Stockholders Agreement dated as of January 28, 1998. (Incorporated herein by reference to Exhibit 10(7) of Playtex's Post Effective Amendment No. 1 to Form S-3, dated as of June 12, 1998, File No. 333-50099.)

10

(aa)

Letter of Waiver, dated as of June 1, 1998, by and among the Company, Donaldson, Lufkin & Jenrette International, J.W. Childs Equity Partners, L.P and certain other Stockholders named in the Stockholders Agreement dated as of January 28, 1998. (Incorporated herein by reference to Exhibit 10(8) of Playtex's Post Effective Amendment No. 1 to Form S-3, dated as of June 12, 1998, File No. 333-50099.)

 

 

 

X-5



10

(ab)

Stock Purchase Agreement, dated June 1, 1998 between J.W. Childs Equity Partners, L.P. (the "seller"), RCBA Playtex, L.P. (the "Buyer"), and Richard C. Blum & Associates, Inc. (the "Guarantor"). (Incorporated herein by reference to Exhibit 10(1) of Playtex's Post Effective Amendment No. 1 to Form S-3, dated as of June 12, 1998, File No. 333-50099.)

10

(ac)

Stockholders Agreement, dated June 1, 1998 between RCBA Playtex, L.P. and the Company. (Incorporated herein by reference to Exhibit 10(2) of Playtex's Post Effective Amendment No. 1 to Form S-3, dated as of June 12, 1998, File No. 333-50099.)

10

(ac)(1)

Amended and Restated Stockholders Agreement, dated September 3, 1998 between the Company, RCBA Playtex, L.P. and RCBA Strategic Partners. (Incorporated herein by reference to Exhibit 10(ac)(1) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

10

(ad)

Registration Rights Agreement, dated June 1, 1998 between RCBA Playtex, L.P. and the Company. (Incorporated herein by reference to Exhibit 10(4) of Playtex's Post Effective Amendment No. 1 to Form S-3, dated as of June 12, 1998, File No. 333-50099.)

10

(ad)(1)

Amendment No. 1, dated as of January 29, 1999, to the Registration Rights Agreement, dated as of June 1, 1998 between RCBA Playtex, L.P. and the Company. (Incorporated herein by reference to Exhibit 10(ad)(1) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

10

(ae)

Registration Rights Agreement, dated as of January 29, 1999, between Playtex Products, Inc. and Mondial Industries Limited Partnership. (Incorporated herein by reference to Exhibit 2.3 of Playtex's Form 8-K, dated February 12, 1999.)

10

(af)

Sublease Agreement between Playtex and AMBAC Capital Management, Inc. dated as of February 20, 1998. (Incorporated herein by reference to Exhibit 10(ah) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

10

(ag)

Agreement of Lease between Playtex Manufacturing, Inc. and Trammell Crow NE, Inc. (Incorporated herein by reference to Exhibit 10(ai) of Playtex's Annual Report on Form 10-K for the fiscal year ended December 26, 1998.)

10

(ah)

Lease Agreement between Playtex Manufacturing, Inc. and Tetra Pak Plastic Packaging R&D GmbH, Hitek FSP, S.A., Tetra Laval Holdings & Finance S.A., and Tetra Laval Credit Inc., dated as of April 26, 1996. (Incorporated herein by reference to Exhibit 10(ai) of Playtex's Annual Report on Form 10-K for the year ended December 27, 1997.)

10

(ai)

Lease Agreement between Playtex Manufacturing, Inc. and BTM Capital Corporation, dated as of June 20, 1996. (Incorporated herein by reference to Exhibit 10(aj) of Playtex's Annual Report on Form 10-K for the year ended December 27, 1997.)

10

(aj)

Interest Rate Swap Agreement effective November 30, 2000 between Playtex Products, Inc., and Wells Fargo Bank, N.A. (Incorporated herein by reference to Exhibit 10(ai) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

 

 

 

X-6



10

(ak)

Interest Rate Swap Agreement effective December 4, 2000 between Playtex Products, Inc., and Toronto Dominion (New York), Inc. (Incorporated herein by reference to Exhibit 10(aj) of Playtex's Annual Report on Form 10-K for the year ended December 30, 2000.)

*12

(a)

Statement re-computation of ratios.

*21

(a)

Subsidiaries of Playtex.

*23

 

Consent of KPMG LLP.

*99

.1

Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*99

.2

Certification by Executive Vice President and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

        Exhibits marked with an "*" are filed as a part of this Annual Report on Form 10-K, all other exhibits are incorporated by reference as individually noted. Exhibits listed as 10(e) through and including 10(o) could be considered compensatory plans or in some manner benefit certain employees.

X-7




QuickLinks

TABLE OF CONTENTS
PART I
Risk Factors
PART II
PART III
PART IV
SIGNATURES
PLAYTEX PRODUCTS, INC. CERTIFICATIONS
PLAYTEX PRODUCTS, INC. CERTIFICATIONS
PLATEX PRODUCTS, INC. 2002 ANNUAL REPORT TO STOCKHOLDERS
PLAYTEX PRODUCTS, INC. SELECTED FINANCIAL DATA (In thousands, except per share data)
PLAYTEX PRODUCTS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
PLAYTEX PRODUCTS, INC. CONSOLIDATED STATEMENTS OF EARNINGS (In thousands, except per share data)
PLAYTEX PRODUCTS, INC. CONSOLIDATED BALANCE SHEETS (In thousands, except share data)
PLAYTEX PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE EARNINGS (In thousands)
PLAYTEX PRODUCTS, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)
Condensed Consolidating Statement of Cash Flows Data For the Twelve Months Ended December 28, 2002 (In thousands)
PLAYTEX PRODUCTS, INC. INDEX TO EXHIBITS